between,correlation,O
mutation,somatic,O
no,observed,O
we,we,O
.,.,O
somatic,mutation,O
and,and,O
the,the,O
Furthermore,Furthermore,O
",",",",O
proliferation,proliferation,O
rate,rate,O
capacity,capacity,O
correlation,between,O
observed,no,O
tissue,tissue,O
,,
difference,difference,O
59,59,O
the,the,O
inter,relative,O
DMAHP,DMAHP,O
relative,inter,O
in,of,O
tissue,tissue,O
three,three,O
genes,genes,O
repeat,repeat,O
somatic,somatic,O
The,The,O
(,(,O
),),O
different,tissues,O
not,not,O
DMPK,DMPK,O
rates,rates,O
were,also,O
of,levels,O
the,the,O
in,in,O
mutation,mutation,O
correlated,to,O
also,were,O
the,surrounding,O
and,and,O
to,correlated,O
",",",",O
.,.,O
surrounding,the,O
.,.,O
-,-,O
levels,transcriptional,O
transcriptional,in,O
tissues,different,O
,,
of,of,O
retinoblastoma,retinoblastoma,B
mutation,mutation,O
phenotype,the,O
in,in,O
showing,pedigree,O
patients,patients,O
only,mild,O
novel,a,O
missense,missense,O
.,.,O
expression,expression,O
a,showing,O
mild,only,O
tumor,tumor,B
the,phenotype,O
A,Novel,O
from,from,O
pedigree,a,O
,,
from,individuals,O
strand,strand,O
retinoblastoma,retinoblastoma,B
the,27,O
a,a,O
We,We,O
of,expression,O
expression,the,O
phenotype,of,O
exons,of,O
the,phenotype,O
polymorphism,polymorphism,O
conformation,conformation,O
the,the,O
showing,mild,O
used,used,O
single,single,O
study,study,O
of,exons,O
family,family,O
in,in,O
to,to,O
27,the,O
individuals,from,O
have,have,O
RB1,RB1,O
.,.,O
gene,gene,O
analysis,analysis,O
mild,showing,O
,,
pedigree,the,O
mutation,mutation,O
carriers,carriers,O
unaffected,unaffected,O
this,family,O
were,were,O
unilateral,unilateral,B
the,pedigree,O
affected,individuals,O
individuals,developed,O
result,of,O
analysis,analysis,O
a,a,O
",",",",O
.,.,O
tumors,tumors,I
",",",",O
In,In,O
within,identified,O
as,and,O
also,also,O
family,this,O
of,result,O
identified,within,O
linkage,linkage,O
and,as,O
developed,affected,O
,,
a,a,O
position,position,O
exon,which,O
exon,exon,O
in,in,O
which,21,O
.,.,O
converting,cys,O
>,>,O
single,single,O
shift,using,O
arg,arg,O
was,was,O
a,converting,O
-,-,O
in,in,O
missense,missense,O
resulted,resulted,O
band,band,O
-,-,O
mutation,mutation,O
SSCP,SSCP,O
the,the,O
using,shift,O
21,exon,O
28,28,O
nucleotide,nucleotide,O
identified,identified,O
cys,a,O
A,A,O
at,at,O
in,in,O
,,
an,an,O
enzyme,site,O
destroyed,mutation,O
NdeI,NdeI,O
mutation,the,O
restriction,restriction,O
The,Destroyed,O
.,.,O
site,enzyme,O
,,
a,result,O
the,the,O
all,of,O
mutation,predisposing,O
with,with,O
-,-,O
patients,patients,O
members,demonstrated,O
the,the,O
Analysis,Analysis,O
demonstrated,members,O
family,family,O
mutation,missense,O
or,or,O
tumors,tumors,B
.,.,O
missense,mutation,O
of,all,O
analysis,had,O
predicted,been,O
that,that,O
predisposing,mutation,O
result,of,O
been,to,O
linkage,linkage,O
",",",",O
of,as,O
who,who,O
had,analysis,O
segregated,segregated,O
to,predicted,O
with,with,O
as,a,O
carry,carry,O
co,co,O
,,
.,.,O
distinctive,distinctive,O
genetic,genetic,O
to,to,O
the,modify,O
another,another,O
These,These,O
the,of,O
mutations,where,O
modify,the,O
phenotypes,phenotypes,O
only,only,O
observations,point,O
these,with,O
families,in,O
point,observations,O
.,.,O
RB1,RB1,O
raise,questions,O
of,the,O
gene,and,O
questions,important,O
where,mutations,O
in,families,O
function,function,O
of,the,O
counseling,counseling,O
with,these,O
the,of,O
region,region,O
and,gene,O
gene,gene,O
important,raise,O
for,for,O
,,
familial,of,O
of,translocation,O
p25,15,O
consistent,and,O
q11,q11,O
),),O
a,a,O
disomy,disomy,I
-,-,I
case,case,O
Willi,Willi,I
syndrome,syndrome,I
),),O
and,Consistent,O
complementation,in,O
2,2,O
(,(,O
with,with,O
Prader,Prader,B
.,.,O
3,3,O
15,p25,O
gamete,gamete,O
;,;,O
Maternal,Maternal,B
;,;,O
translocation,familial,O
in,complementation,O
.,.,O
(,(,O
,,
responsible,responsible,O
syndrome,syndrome,I
Willi,Willi,I
cases,cases,O
of,of,O
for,for,O
PWS,PWS,B
an,an,O
Prader,Prader,B
of,30,O
for,for,I
is,Is,O
.,.,O
(,(,O
(,(,I
-,-,I
30,of,O
),),O
estimated,estimated,O
Maternal,Maternal,B
15,15,I
),),I
disomy,disomy,I
uniparental,uniparental,I
UPD,UPD,I
%,%,O
chromosome,chromosome,I
,,
an,an,O
disomy,disomy,I
),),O
of,of,O
(,(,O
maternal,maternal,B
adjacent,adjacent,O
with,with,O
-,-,O
with,with,O
;,;,O
on,on,O
report,report,O
(,(,O
a,a,O
nondisjunction,meiotic,O
p25,15,O
15,p25,O
consistent,consistent,O
unusual,case,O
1,1,O
t,t,O
.,.,O
2,2,O
We,We,O
paternal,paternal,O
that,that,O
in,in,O
15,15,O
chromosome,for,O
meiotic,nondisjunction,O
maternal,simultaneous,O
simultaneous,maternal,O
.,.,O
q11,q11,O
is,is,O
3,3,O
),),O
of,segregation,O
for,chromosome,O
15,15,I
segregation,of,O
most,most,O
case,unusual,O
PWS,PWS,B
;,;,O
,,
the,the,O
(,(,O
),),O
year,17,O
patient,the,O
distal,and,O
chromosome,chromosome,O
The,Patient,O
B,B,O
have,have,O
supernumerary,supernumerary,O
to,found,O
17,year,O
arm,arm,O
3p,arm,O
and,distal,O
der,der,O
long,long,O
with,a,O
a,with,O
white,old,O
(,(,O
",",",",O
.,.,O
-,-,O
was,was,O
short,short,O
male,with,O
15,15,O
-,-,O
",",",",O
),),O
15,15,O
chromosome,chromosome,O
.,.,O
proximal,proximal,O
.,.,O
and,and,O
",",",",O
PWS,PWS,B
J,J,O
",",",",O
old,white,O
arm,arm,O
of,of,O
47,47,O
paternal,paternal,O
with,male,O
the,the,O
consisting,consisting,O
chromosomes,chromosomes,O
arm,3p,O
a,a,O
of,of,O
found,to,O
,,
3,t,O
patients,patients,O
present,present,O
balanced,balanced,O
;,;,O
the,the,O
state,in,O
),),O
was,was,O
the,state,O
in,in,O
The,The,O
father,father,O
and,and,O
t,3,O
sister,a,O
.,.,O
a,sister,O
in,the,O
15,15,O
(,(,O
,,
present,present,O
normal,pair,O
Fluorescent,Fluorescent,O
demonstrated,that,O
J,in,O
on,region,O
critical,the,O
and,and,O
situ,situ,O
15s,15s,O
of,of,O
that,demonstrated,O
the,critical,O
hybridization,hybridization,O
analysis,analysis,O
region,normal,O
the,on,O
deletion,of,O
the,the,O
that,that,O
on,resided,O
.,.,O
in,J,O
was,was,O
derivative,chromosome,O
no,no,O
in,in,O
3,3,O
of,deletion,O
PWS,PWS,B
the,the,O
there,there,O
PWS,PWS,B
pair,the,O
region,region,O
resided,on,O
chromosome,derivative,O
,,
.,.,O
B,B,O
,,
characteristic,pattern,O
of,characteristic,O
.,.,O
chromosome,maternal,O
small,nuclear,O
maternal,the,O
),),O
J,in,O
nuclear,ribonucleoprotein,O
SNRPN,polypeptide,O
at,at,O
exon,exon,O
polypeptide,N,O
only,only,O
associated,associated,O
in,J,O
the,the,O
(,(,O
the,chromosome,O
-,-,O
gene,gene,O
of,of,O
Methylation,Methylation,O
ribonucleoprotein,small,O
analysis,analysis,O
N,SNRPN,O
pattern,of,O
showed,showed,O
alpha,alpha,O
15,15,O
a,a,O
,,
B,B,O
.,.,O
,,
subunit,beta3,O
the,the,O
.,.,O
Maternal,Maternal,B
locus,GABRB3,O
GABRB3,locus,O
beta3,subunit,O
(,(,O
was,was,O
reaction,reaction,O
-,-,O
aminobutyric,acid,O
polymerase,polymerase,O
at,at,O
receptor,receptor,O
gamma,aminobutyric,O
by,by,O
chain,chain,O
microsatellite,repeats,O
confirmed,confirmed,O
repeats,of,O
),),O
of,microsatellite,O
analysis,analysis,O
acid,gamma,O
disomy,disomy,I
,,
for,that,O
derivative,derivative,O
but,without,O
with,with,O
B,B,O
distal,distal,O
niece,B,O
the,der,O
.,.,O
chromosomes,chromosomes,O
with,with,O
),),O
that,reported,O
A,Niece,O
of,haploinsufficiency,O
a,a,O
.,.,O
der,the,O
(,(,O
45,45,O
.,.,O
haploinsufficiency,of,O
3,3,O
3,3,O
(,(,O
the,the,O
phenotype,phenotype,O
B,a,O
15,15,O
reported,for,O
and,and,O
demonstrated,demonstrated,O
),),O
consistent,consistent,O
without,but,O
p,p,O
,,
previously,previously,O
been,been,O
observed,been,O
case,case,O
associated,Associated,O
our,our,O
with,with,O
-,-,O
has,but,O
.,.,O
of,of,O
",",",",O
non,Robertsonian,O
segregation,segregation,O
",",",",O
PWS,PWS,B
been,observed,O
a,in,O
Robertsonian,non,O
of,of,O
knowledge,knowledge,O
disomy,disomy,I
translocations,translocations,O
but,has,O
in,a,O
has,has,O
not,not,O
reported,reported,O
to,to,O
unbalanced,unbalanced,O
Uniparental,Uniparental,B
,,
15,15,I
in,resulting,O
and,and,O
Furthermore,Furthermore,O
resulting,in,O
PWS,PWS,B
true,as,O
gamete,gamete,O
",",",",O
interpreted,interpreted,O
complementation,complementation,O
are,are,O
findings,findings,O
best,best,O
as,true,O
maternal,maternal,B
our,our,O
UPD,UPD,I
,,
syndrome,syndrome,I
-,-,I
for,for,O
-,-,I
2,2,I
and,and,O
a,a,O
.,.,O
case,case,O
Jampel,Jampel,I
" O
lumping O
"," O
lumping O
",O
:,:,O
Schwartz,Schwartz,B
type,type,I
Stuve,Stuve,B
syndrome,syndrome,I
Wiedemann,Wiedemann,I
,,
existence,existence,O
usually,distinct,O
(,(,O
of,of,O
Recent,Recent,O
lethal,lethal,O
the,the,O
SJS,SJS,B
form,form,O
SJS,SJS,B
myotonia,myotonia,B
dysplasia,dysplasia,I
2,2,I
of,of,O
.,.,O
Schwartz,Schwartz,B
skeletal,skeletal,B
demonstrated,studies,O
syndrome,syndrome,I
we,we,O
Jampel,Jampel,I
genetically,genetically,O
the,the,O
called,called,O
of,which,O
",",",",O
type,type,I
studies,demonstrated,O
",",",",O
and,of,O
which,and,O
distinct,usually,O
-,-,I
a,a,O
),),O
,,
.,.,O
the,the,O
and,and,O
",",",",O
with,with,O
is,is,O
This,This,O
skeletal,skeletal,B
",",",",O
-,-,I
",",",",O
early,early,B
Wiedemann,Wiedemann,I
of,of,O
another,rare,O
dysplasia,dysplasia,I
syndrome,syndrome,I
",",",",O
SWS,SWS,B
),),O
comprises,at,O
Stuve,Stuve,B
disorder,disorder,O
contractures,contractures,B
(,(,O
condition,condition,O
reminiscent,reminiscent,O
birth,comprises,O
campomelia,campomelia,B
death,death,I
at,birth,O
which,which,O
rare,another,O
,,
years,years,O
type,type,I
identity,nosologic,O
up,of,O
and,with,O
follow,follow,O
years,years,O
SJS,SJS,B
with,patients,O
nosologic,identity,O
only,only,O
To,To,O
",",",",O
possible,possible,O
at,at,O
7,7,O
2,2,I
surviving,surviving,O
literature,literature,O
obtained,and,O
the,the,O
age,at,O
.,.,O
the,the,O
one,with,O
of,up,O
a,a,O
and,obtained,O
with,another,O
two,two,O
",",",",O
age,age,O
patients,one,O
test,for,O
SWS,SWS,B
disorders,these,O
these,disorders,O
we,we,O
reviewed,reviewed,O
between,between,O
-,-,O
10,10,O
another,and,O
at,age,O
for,test,O
,,
tendency,tendency,O
reported,reported,O
onset,prenatal,O
prenatal,onset,O
respiratory,with,O
",",",",O
disorder,disorder,I
and,and,O
combination,of,O
having,having,O
-,-,O
to,to,O
skeletal,skeletal,I
-,-,I
death,death,O
with,distinct,O
campomelic,campomelic,B
of,combination,O
and,and,O
distinct,a,O
feeding,feeding,O
SWS,SWS,B
neonatal,neonatal,O
infancy,in,O
.,.,O
a,with,O
",",",",O
),),O
a,a,O
joint,joint,I
contractures,contractures,I
a,a,O
dysplasia,dysplasia,I
",",",",O
with,respiratory,O
difficulties,difficulties,O
neuromuscular,neuromuscular,B
congenital,congenital,B
metaphyseal,metaphyseal,I
(,(,O
hyperthermia,hyperthermia,B
Patients,Patients,O
either,either,O
severe,severe,O
presented,or,O
",",",",O
in,infancy,O
or,presented,O
frequent,frequent,O
as,as,O
SJS,SJS,B
,,
findings,and,O
is,is,O
single,a,O
and,radiographic,O
The,The,O
extensive,so,O
that,that,O
disorders,appear,O
clinical,the,O
appear,disorders,O
of,of,O
these,these,O
entity,entity,O
the,clinical,O
to,to,O
be,be,O
radiographic,findings,O
a,single,O
so,extensive,O
similarity,similarity,O
.,.,O
,,
progressive,of,O
-,-,O
one,with,O
in,in,O
the,to,O
SWS,SWS,B
adds,adds,O
",",",",O
of,progressive,O
an,an,O
),),O
one,one,O
favor,identity,O
evidence,evidence,O
dysplasia,dysplasia,I
and,identical,O
.,.,O
in,in,O
with,one,O
of,of,O
pattern,pattern,O
SJS,SJS,B
surviving,beyond,O
bone,bone,B
two,the,O
beyond,surviving,O
to,the,O
(,(,O
unique,and,O
identity,of,O
follow,the,O
with,with,O
the,two,O
observation,observation,O
up,up,O
The,Follow,O
type,type,I
patients,patients,O
2,2,I
infancy,infancy,O
identical,unique,O
of,favor,O
,,
are,the,O
that,and,O
The,The,O
should,be,O
.,.,O
.,.,O
2,2,I
SWS,SWS,B
the,are,O
type,type,I
be,should,O
methods,methods,O
SJS,SJS,B
and,that,O
by,testable,O
disorder,same,O
molecular,molecular,O
hypothesis,hypothesis,O
same,disorder,O
testable,by,O
,,
defects,defects,O
of,severe,O
disease,disease,I
thrombosis,thrombosis,B
von,von,B
model,model,O
.,.,O
:,:,O
severe,of,O
A,A,O
mouse,mouse,O
hemostasis,hemostasis,O
Willebrand,Willebrand,I
in,in,O
and,and,O
,,
),),I
severe,causes,O
Willebrand,Willebrand,I
causes,severe,O
in,humans,O
von,von,B
.,.,O
factor,factor,I
von,von,B
vWf,vWf,I
Willebrand,Willebrand,I
humans,in,O
disease,disease,I
(,(,I
deficiency,deficiency,I
,,
targeting,gene,O
mouse,mouse,O
disease,by,O
a,a,O
using,using,O
We,Generated,O
model,model,O
by,this,O
for,for,O
generated,we,O
.,.,O
this,disease,O
gene,targeting,O
,,
;,;,O
deficient,deficient,I
appeared,appeared,O
fertile,and,O
they,birth,O
.,.,O
-,-,I
birth,were,O
vWf,vWf,B
normal,normal,O
and,fertile,O
mice,mice,O
were,they,O
viable,viable,O
at,at,O
,,
the,homozygous,O
mice,mice,O
plasma,plasma,O
platelets,platelets,O
(,(,O
",",",",O
detectable,were,O
homozygous,the,O
",",",",O
Willebrand,Willebrand,I
von,von,B
),),O
were,detectable,O
endothelial,cells,O
or,or,O
cells,endothelial,O
in,in,O
nor,nor,O
antigen,antigen,O
.,.,O
propolypeptide,propolypeptide,O
of,of,O
vWf,neither,O
vWf,vWf,O
II,II,O
mutant,mutant,O
Neither,vWf,O
,,
of,10,O
prolonged,highly,O
events,events,O
bleeding,bleeding,O
in,in,O
and,spontaneous,O
a,a,O
bleeding,bleeding,O
exhibited,defects,O
10,approximately,O
The,Mutant,O
with,with,O
mice,mice,O
%,%,O
defects,exhibited,O
spontaneous,time,O
highly,prolonged,O
.,.,O
neonates,neonates,O
mutant,the,O
in,in,O
time,and,O
hemostasis,hemostasis,O
approximately,of,O
,,
provided,protection,O
in,in,O
strongly,strongly,O
factor,factor,O
in,these,O
of,of,O
as,a,O
was,reduced,O
of,the,O
a,of,O
by,by,O
disease,disease,O
VIII,VIII,O
the,the,O
these,level,O
result,as,O
",",",",O
the,the,O
level,in,O
the,result,O
mice,mice,O
lack,lack,O
protection,provided,O
vWf,vWf,O
human,human,O
reduced,was,O
.,.,O
As,As,O
,,
injury,injury,I
vivo,model,O
mutant,mutant,O
an,an,O
thrombosis,thrombosis,B
Defective,Defective,O
vascular,vascular,B
.,.,O
of,of,O
in,in,O
model,vivo,O
in,in,O
in,evident,O
was,mice,O
also,was,O
evident,in,O
mice,also,O
,,
the,the,O
of,of,O
by,intravital,O
chloride,ferric,O
",",",",O
In,In,O
was,was,O
model,model,O
exteriorized,exteriorized,O
and,the,O
this,this,O
accumulation,accumulation,O
observed,was,O
mesentery,mesentery,O
superfused,superfused,O
ferric,chloride,O
.,.,O
microscopy,by,O
labeled,labeled,O
was,observed,O
with,with,O
platelets,platelets,O
the,and,O
fluorescently,fluorescently,O
intravital,microscopy,O
,,
mimic,mimic,O
these,these,O
in,in,O
in,normal,O
very,closely,O
vWf,vWf,O
mice,mice,O
Willebrand,Willebrand,I
von,von,B
disease,models,O
human,will,O
.,.,O
the,the,O
physiology,and,O
investigating,investigating,O
normal,in,O
models,disease,O
that,that,O
will,and,O
be,very,O
for,useful,O
and,human,O
useful,for,O
severe,severe,O
closely,very,O
very,be,O
We,Conclude,O
of,of,O
.,.,O
disease,disease,I
role,role,O
and,physiology,O
conclude,we,O
,,
ovarian,ovarian,I
.,.,O
of,risk,O
risk,of,O
hereditary,hereditary,B
and,and,O
Oral,Contraceptives,O
cancer,cancer,I
contraceptives,oral,O
the,the,O
,,
Ovarian,Ovarian,I
Study,clinical,O
Clinical,Study,O
Group,Group,O
.,.,O
Cancer,Cancer,I
Hereditary,Hereditary,B
,,
BRCA1,or,O
of,risk,O
with,with,O
a,a,O
either,mutations,O
Women,BACKGROUND,O
BRCA2,BRCA2,O
high,high,O
risk,of,O
the,the,O
mutations,in,O
BACKGROUND,Women,O
cancer,cancer,I
lifetime,lifetime,O
.,.,O
the,the,O
ovarian,ovarian,B
or,BRCA1,O
gene,have,O
have,gene,O
in,either,O
,,
not,not,O
of,of,I
against,protect,O
in,in,O
protect,contraceptives,O
",",",",O
.,.,O
it,is,O
contraceptives,oral,O
against,against,O
cancer,cancer,I
protect,protect,O
cancer,cancer,I
Oral,Against,O
also,also,O
ovarian,ovarian,B
but,it,O
general,general,O
is,but,O
whether,whether,O
forms,forms,I
ovarian,ovarian,I
hereditary,hereditary,B
known,known,O
they,they,O
,,
161,of,O
a,in,O
cancer,cancer,I
-,-,O
and,and,O
ovarian,ovarian,I
case,case,O
in,a,O
.,.,O
as,as,O
hereditary,hereditary,B
of,their,O
study,control,O
their,161,O
women,women,O
with,with,O
sisters,sisters,O
207,enrolled,O
We,METHODS,O
controls,controls,O
enrolled,207,O
METHODS,We,O
control,study,O
,,
women,women,O
or,BRCA2,O
179,BRCA1,O
women,28,O
BRCA2,or,O
),),O
the,all,O
in,either,O
(,(,O
BRCA1,179,O
28,women,O
patients,patients,O
carried,carried,O
mutation,mutation,O
),),O
a,a,O
pathogenic,pathogenic,O
(,(,O
.,.,O
All,The,O
either,in,O
,,
of,of,O
enrolled,regardless,O
they,they,O
women,control,O
were,were,O
The,Women,O
not,not,O
control,the,O
either,either,O
whether,whether,O
regardless,enrolled,O
.,.,O
or,or,O
mutation,mutation,O
had,had,O
,,
-,-,O
patients,compared,O
and,were,O
by,by,O
and,control,O
contraceptive,contraceptive,O
by,by,O
histories,lifetime,O
",",",",O
and,and,O
of,of,O
for,adjustment,O
or,interview,O
year,year,O
of,of,O
questionnaire,and,O
control,and,O
compared,between,O
Lifetime,Histories,O
oral,oral,O
interview,or,O
birth,birth,O
were,use,O
adjustment,for,O
obtained,obtained,O
written,written,O
were,questionnaire,O
parity,parity,O
after,after,O
between,patients,O
women,women,O
use,were,O
.,.,O
,,
adjusted,adjusted,O
contraceptives,was,O
past,past,O
ovarian,ovarian,B
The,The,O
cancer,cancer,I
odds,ratio,O
.,.,O
ratio,odds,O
any,any,O
associated,for,O
RESULTS,RESULTS,O
was,contraceptives,O
for,associated,O
0,0,O
with,with,O
of,of,O
oral,oral,O
use,use,O
,,
to,to,O
95,percent,O
5,5,O
.,.,O
),),O
.,.,O
interval,0,O
",",",",O
.,.,O
(,(,O
8,8,O
percent,confidence,O
confidence,95,O
3,3,O
0,interval,O
0,0,O
,,
use,001,O
percent,percent,O
use,of,O
.,.,O
;,;,O
.,.,O
",",",",O
a,a,O
duration,duration,O
was,was,O
decreased,decreased,O
risk,risk,O
more,or,O
six,six,O
P,P,O
for,for,O
0,0,O
60,60,O
of,use,O
001,use,O
trend,for,O
in,reduction,O
The,The,O
<,<,O
risk,risk,O
with,with,O
with,with,O
(,(,O
or,more,O
),),O
associated,associated,O
increasing,increasing,O
years,years,O
reduction,in,O
for,trend,O
,,
",",",",O
mutation,BRCA1,O
contraceptive,use,O
),),O
ratio,odds,O
(,(,O
.,.,O
-,-,O
percent,percent,O
to,0,O
odds,odds,O
the,the,O
2,2,O
BRCA1,mutation,O
odds,ratio,O
0,3,O
percent,percent,O
.,.,O
interval,interval,O
),),O
both,both,O
to,1,O
mutation,mutation,O
protected,protected,O
0,0,O
interval,interval,O
of,the,O
for,for,O
ratio,ratio,O
9,9,O
95,95,O
;,;,O
1,to,O
95,95,O
ovarian,ovarian,B
carriers,carriers,O
against,against,O
.,.,O
0,0,O
;,;,O
",",",",O
.,.,O
and,and,O
confidence,confidence,O
BRCA2,BRCA2,O
for,for,O
0,to,O
1,1,O
the,of,O
use,oral,O
.,.,O
.,.,O
carriers,carriers,O
cancer,cancer,I
0,0,O
Oral,Contraceptive,O
confidence,confidence,O
.,.,O
of,of,O
",",",",O
3,0,O
",",",",O
4,4,O
5,5,O
(,(,O
,,
of,risk,O
the,the,O
gene,BRCA2,O
the,the,O
in,pathogenic,O
cancer,cancer,I
women,women,O
or,or,O
BRCA2,gene,O
-,-,O
BRCA1,BRCA1,O
pathogenic,mutations,O
with,with,O
reduce,reduce,O
mutations,in,O
Oral,CONCLUSIONS,O
ovarian,ovarian,B
risk,of,O
contraceptive,Oral,O
may,may,O
CONCLUSIONS,contraceptive,O
in,in,O
use,use,O
,,
adrenoleukodystrophy,adrenoleukodystrophy,B
A,A,O
and,report,O
",",",",O
",",",",O
clinical,clinical,O
:,:,O
with,with,O
a,codon,O
deletion,deletion,O
Japanese,family,O
codon,a,O
pathological,biochemical,O
.,.,O
291,291,O
report,genetic,O
a,a,O
genetic,and,O
with,with,O
family,Japanese,O
",",",",O
biochemical,pathological,O
,,
base,base,O
adrenoleukodystrophy,adrenoleukodystrophy,B
a,Japanese,O
the,in,O
ALD,ALD,B
delGAG,291,O
with,family,O
(,(,O
three,a,O
a,three,O
gene,gene,O
with,with,O
We,We,O
pair,pair,O
ALD,ALD,B
291,delGAG,O
Japanese,with,O
),),O
(,(,O
in,the,O
.,.,O
report,report,O
deletion,deletion,O
),),O
family,a,O
,,
within,within,O
were,phenotypes,O
observed,observed,O
family,this,O
of,variety,O
.,.,O
this,family,O
variety,of,O
phenotypes,were,O
A,A,O
,,
(,(,O
),),O
cerebello,and,O
brother,younger,O
younger,brother,O
2,2,O
-,-,O
type,intermediate,O
having,having,O
and,cerebello,O
classified,as,O
as,classified,O
patient,patient,O
),),O
was,was,O
.,.,O
intermediate,type,O
and,and,O
(,(,O
adult,cerebral,O
type,childhood,O
),),O
proband,proband,O
forms,forms,O
3,had,O
brain,brain,O
rare,a,O
(,(,O
",",",",O
his,his,O
patient,1,O
1,patient,O
patient,nephew,O
While,While,O
a,a,O
stem,stem,O
the,the,O
of,of,O
nephew,patient,O
childhood,type,O
cerebral,adult,O
had,3,O
ALD,ALD,B
a,rare,O
,,
4,4,O
(,(,O
as,an,O
form,adolescent,O
.,.,O
an,having,O
adolescent,form,O
),),O
of,of,O
patient,patient,O
nephew,nephew,O
classified,as,O
Another,Another,O
1,patient,O
patient,1,O
was,was,O
having,classified,O
,,
of,that,O
that,of,O
AD,AD,B
as,as,O
fluid,fluid,O
CSF,CSF,O
),),O
patients,patients,O
The,The,O
(,(,O
),),O
with,with,O
in,1,O
tau,tau,O
1,patient,O
was,as,O
Alzheimers,Alzheimers,B
.,.,O
as,was,O
(,(,O
disease,disease,I
high,high,O
patient,in,O
in,level,O
cerebrospinal,the,O
the,cerebrospinal,O
level,in,O
,,
cerebral,the,O
oxygen,oxygen,O
His,Magnetic,O
were,were,O
in,not,O
),),O
.,.,O
flow,flow,O
image,MRI,O
emission,emission,O
the,the,I
matter,matter,O
not,in,O
abnormalities,abnormalities,B
in,in,I
and,and,O
(,(,O
cerebral,cerebral,O
of,of,O
PET,PET,O
white,white,O
reductions,reductions,O
the,the,O
",",",",O
resonance,resonance,O
brain,brain,O
(,(,O
MRI,image,O
the,cerebral,O
stem,stem,O
cerebellar,cerebellar,I
brain,his,O
blood,blood,O
tomography,tomography,O
hemispheres,hemispheres,I
clearly,clearly,O
and,and,O
positron,demonstrated,O
where,marked,O
",",",",O
metabolism,metabolism,O
showed,showed,O
bilateral,bilateral,I
magnetic,brain,O
),),O
by,positron,O
but,but,O
marked,where,O
demonstrated,by,O
,,
2,and,O
compatible,with,O
",",",",O
cerebral,cerebral,I
of,of,I
3,3,O
of,of,O
fibers,fibers,O
",",",",O
matter,matter,I
findings,of,O
.,.,O
-,-,O
ALD,ALD,B
with,with,O
with,compatible,O
demyelination,demyelination,B
the,the,O
the,the,O
massive,massive,O
showed,showed,O
autopsy,findings,O
of,childhood,O
the,the,O
sparing,sparing,O
childhood,findings,O
white,white,I
and,2,O
findings,autopsy,O
U,U,O
patients,patients,O
In,In,O
the,the,I
,,
were,Oil,O
acids,acids,O
not,was,O
Oil,were,O
(,(,O
),),O
erucic,and,O
effectiveness,effectiveness,O
sufficient,sufficient,O
Lorenzos,Lorenzos,O
",",",",O
and,and,O
Oleic,Oleic,O
1,patients,O
obtained,obtained,O
to,administered,O
4,but,O
was,not,O
but,4,O
patients,1,O
administered,to,O
and,erucic,O
.,.,O
,,
phenotypic,phenotypic,O
cause,of,O
family,family,O
of,cause,O
ALD,ALD,B
.,.,O
that,suggest,O
The,The,O
with,with,O
in,findings,O
delGAG291,is,O
variations,variations,O
the,the,O
is,delGAG291,O
of,of,O
part,part,O
Japanese,Japanese,O
findings,in,O
suggest,that,O
this,this,O
,,
neuronal,neuronal,B
or,or,O
analysis,MRI,O
which,is,O
tomogram,computed,O
that,that,O
PET,PET,O
reflects,reflects,O
that,that,O
insidious,insidious,B
.,.,O
tau,tau,O
lesion,lesion,I
Moreover,Moreover,O
the,the,O
process,of,O
and,and,O
detect,an,O
there,limited,O
),),O
of,process,O
the,the,O
can,detect,O
the,is,O
study,study,O
limited,there,O
by,by,O
(,(,O
MRI,analysis,O
CT,CT,O
possibility,possibility,O
is,which,O
scale,scale,O
undetectable,undetectable,O
the,the,O
of,of,O
computed,tomogram,O
in,in,O
level,level,O
a,a,O
although,although,O
",",",",O
",",",",O
higher,higher,O
is,is,O
is,the,O
",",",",O
an,can,O
degeneration,degeneration,I
of,of,O
ALD,ALD,B
,,
.,.,O
stage,early,O
should,be,O
.,.,O
Lorenzos,Lorenzos,O
early,the,O
the,stage,O
in,in,O
given,given,O
be,should,O
Oil,Oil,O
,,
C9,C9,I
deficiency,deficiency,I
of,of,O
C9,gene,O
Japanese,Japanese,O
exon,4,O
major,cause,O
gene,C9,O
of,of,O
.,.,O
human,human,O
4,exon,O
complement,complement,B
in,in,O
complement,complement,O
Nonsense,Mutation,O
cause,the,O
the,major,O
is,is,O
mutation,nonsense,O
,,
of,of,I
but,but,O
complement,complement,B
in,in,O
Deficiency,Deficiency,B
ninth,ninth,I
other,other,O
is,the,O
the,the,I
Japan,in,O
deficiency,deficiency,I
is,is,O
component,component,I
most,common,O
countries,countries,O
human,human,I
the,C9,O
of,of,I
common,most,O
complement,complement,I
rare,rare,O
(,(,O
in,Japan,O
C9,is,O
.,.,O
),),O
,,
deficient,deficient,I
the,the,O
of,in,O
had,had,O
who,patients,O
molecular,molecular,O
studied,studied,O
meningococcal,meningococcal,B
-,-,I
.,.,O
from,suffered,O
deficiency,deficiency,I
patients,who,O
C9,C9,B
suffered,from,O
C9,C9,B
We,We,O
basis,basis,O
Japanese,Japanese,O
meningitis,meningitis,I
four,four,O
in,of,O
,,
TGA,at,O
nonsense,nonsense,O
Direct,Sequencing,O
in,in,O
in,95,O
-,-,O
substitution,CGA,O
C9,C9,B
CGA,substitution,O
cDNA,and,O
95,in,O
at,TGA,O
and,cDNA,O
),),O
individuals,four,O
C9,C9,O
4,exon,O
the,individuals,O
a,a,O
-,-,I
four,the,O
amplified,amplified,O
DNA,DNA,O
exon,4,O
revealed,revealed,O
>,>,O
.,.,O
sequencing,direct,O
-,-,O
of,of,O
deficient,deficient,I
codon,codon,O
(,(,O
,,
one,only,O
indicated,indicated,O
in,in,O
the,the,O
polymerase,chain,O
specific,specific,O
chain,polymerase,O
allele,allele,O
that,that,O
2,heterozygous,O
were,were,O
of,of,O
and,4,O
all,the,O
mutant,alleles,O
the,the,O
for,homozygous,O
-,-,O
four,four,O
system,system,O
the,all,O
mutation,mutation,O
were,2,O
4,and,O
the,the,O
exclusively,exclusively,O
and,mutant,O
parents,parents,O
exon,exon,O
that,that,O
normal,normal,O
to,detect,O
.,.,O
detect,to,O
only,one,O
An,An,O
heterozygous,were,O
alleles,and,O
patient,patient,O
reaction,reaction,O
homozygous,for,O
designed,designed,O
patients,patients,O
of,of,O
,,
be,might,O
responsible,be,O
Japanese,Japanese,O
most,most,O
for,for,O
The,Mutation,O
codon,codon,O
mutation,common,O
in,95,O
.,.,O
95,in,O
deficiency,deficiency,I
might,responsible,O
.,.,O
exon,exon,O
4,4,O
common,the,O
C9,C9,B
at,at,O
,,
damage,damage,O
required,BRCA1,O
DNA,oxidative,O
-,-,O
BRCA1,Required,O
.,.,O
oxidative,of,O
coupled,coupled,O
repair,repair,O
of,DNA,O
for,for,O
transcription,transcription,O
,,
breast,breast,B
function,function,O
.,.,O
ovarian,ovarian,I
BRCA1,gene,O
encodes,encodes,O
cancer,cancer,I
and,and,I
zinc,finger,O
unknown,unknown,O
of,protein,O
finger,a,O
susceptibility,susceptibility,O
gene,BRCA1,O
a,zinc,O
protein,of,O
The,The,O
,,
with,protein,O
damaging,DNA,O
DNA,the,O
in,changes,O
consistent,with,O
BRCA1,BRCA1,O
and,and,O
the,the,O
protein,Rad51,O
Association,Association,O
agents,agents,O
the,the,O
protein,with,O
a,a,O
for,BRCA1,O
the,DNA,O
repair,repair,O
with,consistent,O
DNA,DNA,O
role,role,O
Rad51,protein,O
in,in,O
changes,in,O
to,to,O
of,of,O
localization,of,O
repair,repair,O
cellular,cellular,O
the,the,O
of,localization,O
phosphorylation,phosphorylation,O
-,-,O
are,are,O
protein,after,O
.,.,O
and,and,O
DNA,damaging,O
BRCA1,for,O
exposure,protein,O
after,exposure,O
,,
it,it,O
",",",",O
DNA,oxidative,O
of,of,O
to,to,O
damage,and,O
Here,Here,O
coupled,coupled,O
deficient,deficient,B
cells,are,O
defective,defective,O
hydrogen,hydrogen,O
peroxide,peroxide,O
hypersensitive,to,O
in,ability,O
mouse,mouse,O
is,is,O
.,.,O
out,carry,O
",",",",O
to,hypersensitive,O
and,damage,O
embryonic,embryonic,O
carry,out,O
radiation,ionizing,O
transcription,transcription,O
and,and,O
shown,shown,O
the,in,O
-,-,O
ionizing,radiation,O
oxidative,DNA,O
in,in,I
that,that,O
BRCA1,BRCA1,I
are,cells,O
ability,the,O
stem,stem,O
are,are,O
repair,repair,O
,,
damage,damage,O
.,.,O
suggest,results,O
in,in,O
of,oxidative,O
BRCA1,participates,O
-,-,O
directly,or,O
DNA,DNA,O
that,that,O
",",",",O
repair,repair,O
coupled,coupled,O
",",",",O
results,suggest,O
transcription,transcription,O
participates,BRCA1,O
oxidative,of,O
.,.,O
or,directly,O
indirectly,indirectly,O
These,These,O
,,
result,in,O
.,.,O
of,PAX6,O
the,transactivation,O
region,region,O
-,-,O
negative,negative,O
PAX6,of,O
mutants,mutants,O
Truncation,Truncation,O
dominant,result,O
in,in,O
transactivation,the,O
mutations,mutations,O
in,dominant,O
,,
proline,proline,O
homeobox,homeobox,O
DNA,binding,O
domain,transactivation,O
threonine,serine,O
two,two,O
(,(,O
PAX6,PAX6,O
.,.,O
domains,domains,O
box,and,O
PST,rich,O
binding,DNA,O
a,a,O
paired,paired,O
a,a,O
),),O
serine,threonine,O
and,box,O
transactivation,domain,O
transcription,factor,O
-,-,O
factor,with,O
),),O
with,transcription,O
is,is,O
rich,PST,O
and,and,O
(,(,O
-,-,O
-,-,O
-,-,O
,,
.,.,O
regulates,eye,O
humans,to,O
development,development,O
to,Drosophila,O
in,in,O
to,humans,O
ranging,ranging,O
Drosophila,to,O
from,jellyfish,O
animals,animals,O
eye,regulates,O
jellyfish,from,O
PAX6,PAX6,O
,,
.,.,O
the,human,O
",",",",O
Peters,Peters,B
in,various,O
anomaly,anomaly,I
various,in,O
result,gene,O
foveal,foveal,I
aniridia,aniridia,B
and,and,O
familial,familial,B
PAX6,result,O
",",",",O
mutations,mutations,O
Heterozygous,Heterozygous,O
human,the,O
keratitis,keratitis,I
",",",",O
",",",",O
autosomal,autosomal,B
gene,PAX6,O
including,including,O
dysplasia,dysplasia,I
phenotypes,phenotypes,O
in,in,O
dominant,dominant,I
,,
mutated,allele,O
of,of,O
due,due,O
and,protein,O
that,that,O
believed,believed,O
haploinsufficiency,haploinsufficiency,O
inactive,inactive,O
allele,mutated,O
aniridia,aniridia,B
It,It,O
is,is,O
produces,produces,O
caused,caused,O
genetic,genetic,O
to,to,O
.,.,O
an,an,O
the,the,O
protein,and,O
is,is,O
PAX6,PAX6,O
,,
transactivation,transactivation,O
",",",",O
DNA,binding,O
mutations,mutations,O
domains,domains,O
found,to,O
the,of,O
been,have,O
proteins,mutant,O
in,in,O
mutant,proteins,O
to,occur,O
several,several,O
in,in,O
-,-,O
occur,found,O
However,However,O
patients,patients,O
binding,DNA,O
lost,lost,O
of,most,O
C,C,O
half,of,O
the,retain,O
have,have,O
-,-,O
resulting,in,O
truncation,truncation,O
in,resulting,O
most,the,O
of,half,O
domain,domain,O
but,but,O
that,that,O
Aniridia,Aniridia,B
PAX6,PAX6,O
the,the,O
with,with,O
terminal,terminal,O
retain,the,O
have,been,O
.,.,O
,,
as,as,O
of,mutants,O
clear,clear,O
-,-,O
such,such,O
loss,as,O
mutants,function,O
function,of,O
predicted,predicted,O
as,loss,O
It,It,O
.,.,O
mutants,mutants,O
is,not,O
behave,behave,O
by,by,O
haploinsufficiency,haploinsufficiency,O
not,is,O
whether,whether,O
-,-,O
really,really,O
,,
showed,data,O
they,when,O
mutants,mutants,O
our,our,O
negative,negative,O
are,coexpressed,O
",",",",O
Contrary,To,O
when,they,O
theory,this,O
assays,assays,O
with,wild,O
transfection,transfection,O
dominant,are,O
coexpressed,with,O
-,-,O
-,-,O
type,type,O
PAX6,PAX6,O
data,showed,O
that,that,O
these,these,O
transient,transient,O
this,theory,O
to,contrary,O
.,.,O
in,in,O
are,dominant,O
wild,are,O
,,
-,-,O
enhanced,enhanced,O
these,of,O
result,from,O
dominant,negative,O
from,result,O
DNA,DNA,O
found,we,O
binding,ability,O
We,Found,O
negative,dominant,O
the,the,O
.,.,O
ability,binding,O
the,the,O
mutants,these,O
that,that,O
effects,effects,O
of,mutants,O
,,
dissociation,dissociation,O
studies,studies,O
the,the,O
PAX6,type,O
various,to,O
-,-,O
.,.,O
Kinetic,Kinetic,O
binding,binding,O
when,when,O
that,various,O
truncation,mutants,O
of,of,O
affinity,various,O
to,higher,O
-,-,O
and,binding,O
-,-,O
-,-,O
revealed,revealed,O
higher,affinity,O
wild,PAX6,O
DNA,DNA,O
type,wild,O
sites,sites,O
have,have,O
compared,compared,O
3,5,O
various,that,O
5,3,O
mutants,truncation,O
with,with,O
fold,fold,O
binding,and,O
,,
provide,results,O
a,insight,O
of,role,O
insight,new,O
the,into,O
aniridia,aniridia,B
new,a,O
PAX6,PAX6,O
in,in,O
into,the,O
.,.,O
results,provide,O
mutant,mutant,O
causing,causing,O
These,These,O
.,.,O
role,of,O
,,
very,very,B
coenzyme,coenzyme,I
in,in,O
cardiomyopathy,cardiomyopathy,I
-,-,I
.,.,O
Reversal,Reversal,O
acyl,acyl,I
of,of,O
-,-,I
long,long,I
dehydrogenase,dehydrogenase,I
deficiency,deficiency,I
outcome,outcome,O
severe,neuropsychologic,O
chain,chain,I
excellent,and,O
-,-,I
A,A,I
and,severe,O
neuropsychologic,excellent,O
hypertrophic,hypertrophic,B
,,
a,a,O
VLCAD,VLCAD,I
is,is,O
A,A,I
reportedly,has,O
Very,Very,B
acid,acid,O
that,that,O
long,long,I
of,morbidity,O
rates,high,O
),),I
and,and,O
dehydrogenase,dehydrogenase,I
coenzyme,coenzyme,I
deficiency,deficiency,I
of,fatty,O
oxidation,oxidation,O
-,-,I
morbidity,of,O
(,(,I
chain,chain,I
.,.,O
has,rates,O
-,-,I
fatty,disorder,O
acyl,acyl,I
beta,beta,O
mortality,mortality,O
high,reportedly,O
disorder,of,O
-,-,I
,,
with,with,O
a,5,O
severe,and,O
was,was,O
describe,we,O
5,a,O
age,age,O
of,of,O
",",",",O
at,at,O
-,-,O
outcome,of,O
hepatomegaly,hepatomegaly,B
5,5,O
year,year,O
seen,seen,O
.,.,O
deficiency,deficiency,I
",",",",O
first,first,O
cardiomyopathy,cardiomyopathy,I
hypotonia,hypotonia,B
We,Describe,O
and,severe,O
of,outcome,O
hypertrophic,hypertrophic,B
girl,old,O
who,who,O
with,with,O
old,girl,O
",",",",O
months,months,O
the,the,O
VLCAD,VLCAD,B
encephalopathy,encephalopathy,B
-,-,O
,,
VLCAD,VLCAD,B
enzyme,enzyme,O
inactive,inactive,O
a,a,O
studies,biochemical,O
indicated,studies,O
yet,yet,O
Biochemical,Indicated,O
by,caused,O
deficiency,deficiency,I
stable,stable,O
caused,by,O
.,.,O
,,
1669,1669,O
mutation,mutation,O
genetic,of,O
1668,1668,O
),),O
site,mutation,O
and,a,O
analysis,genetic,O
ACAG,ACAG,O
(,(,O
Molecular,Molecular,O
gene,VLCAD,O
splice,splice,O
missense,missense,O
T1372C,T1372C,O
a,and,O
revealed,gene,O
her,her,O
VLCAD,a,O
F458L,F458L,O
a,revealed,O
mutation,site,O
.,.,O
of,analysis,O
,,
triglyceride,triglyceride,O
After,After,O
with,medium,O
-,-,O
of,avoidance,O
avoidance,and,O
-,-,O
treatment,initial,O
and,of,O
the,carnitine,O
low,a,O
glucose,and,O
supplemented,supplemented,O
carnitine,patient,O
fasting,fasting,O
and,glucose,O
a,low,O
carnitine,and,O
and,carnitine,O
intravenous,intravenous,O
initial,treatment,O
diet,diet,O
.,.,O
",",",",O
fat,fat,O
oil,oil,O
medium,with,O
on,on,O
has,has,O
chain,chain,O
with,with,O
thrived,thrived,O
patient,the,O
,,
over,over,O
1,year,O
Her,Ventricular,O
.,.,O
significantly,resolved,O
",",",",O
hypertrophy,hypertrophy,O
ventricular,her,O
the,the,O
year,1,O
and,cognitively,O
range,age,O
",",",",O
resolved,significantly,O
in,in,O
age,for,O
superior,superior,O
cognitively,and,O
for,range,O
is,is,O
she,she,O
,,
one,one,O
children,children,O
of,of,O
in,of,O
is,is,O
it,it,O
because,because,O
cardiomyopathy,cardiomyopathy,B
causes,directly,O
of,is,O
of,in,O
.,.,O
VLCAD,VLCAD,B
directly,treatable,O
Clinical,Recognition,O
.,.,O
important,important,O
deficiency,deficiency,I
treatable,causes,O
few,the,O
the,few,O
is,of,O
recognition,clinical,O
,,
low,low,O
lipoprotein,density,O
Cloning,Cloning,O
.,.,O
of,of,O
density,lipoprotein,O
the,the,O
novel,of,O
member,member,O
-,-,O
receptor,receptor,O
of,novel,O
family,family,O
a,a,O
,,
by,DNA,O
protein,was,O
chromosome,11q13,O
transmembrane,novel,O
diabetes,diabetes,I
analysis,sequence,O
11q13,chromosome,O
on,on,O
sequence,analysis,O
IDDM4,IDDM4,O
),),O
locus,locus,O
(,(,O
gene,gene,O
encoding,encoding,O
was,identified,O
mellitus,mellitus,I
IDDM,IDDM,B
-,-,I
insulin,insulin,B
A,A,O
.,.,O
dependent,dependent,I
DNA,by,O
a,a,O
identified,protein,O
the,the,O
within,within,O
novel,transmembrane,O
,,
susceptibility,susceptibility,O
Based,Based,O
for,candidate,O
a,is,O
gene,gene,O
.,.,O
this,this,O
position,chromosomal,O
to,to,O
on,its,O
diabetes,diabetes,B
conferring,conferring,O
candidate,a,O
",",",",O
chromosomal,position,O
its,on,O
is,for,O
,,
conserved,conserved,O
which,are,O
termed,termed,O
-,-,O
density,density,O
5,LRP5,O
that,1615,O
-,-,O
receptor,family,O
contains,contains,O
The,The,O
),),O
",",",",O
lipoprotein,receptor,O
protein,of,O
related,related,O
a,a,O
modules,modules,O
1615,amino,O
protein,protein,O
(,(,O
family,receptor,O
density,density,O
characteristic,of,O
low,low,O
(,(,O
encodes,encodes,O
),),O
lipoprotein,LDL,O
low,low,O
are,which,O
",",",",O
.,.,O
the,the,O
amino,acids,O
of,characteristic,O
of,protein,O
LDL,lipoprotein,O
receptor,lipoprotein,O
LRP5,5,O
acids,that,O
gene,gene,O
,,
modules,these,O
",",",",O
",",",",O
domain,domain,O
for,for,O
),),O
repeats,EGF,O
four,growth,O
receptor,receptor,O
with,with,O
putative,putative,O
include,include,O
(,(,O
),),O
growth,factor,O
.,.,O
",",",",O
repeats,repeats,O
These,Modules,O
LDL,three,O
domains,LDL,O
epidermal,four,O
a,a,O
peptide,peptide,O
export,protein,O
associated,spacer,O
signal,signal,O
a,a,O
and,and,O
protein,export,O
",",",",O
domain,domain,O
spacer,associated,O
spanning,spanning,O
cytoplasmic,cytoplasmic,O
-,-,O
a,a,O
factor,epidermal,O
transmembrane,single,O
LDLR,LDLR,O
single,transmembrane,O
three,domains,O
EGF,repeats,O
(,(,O
,,
family,family,O
of,of,O
category,category,O
and,and,O
protein,protein,O
has,has,O
unique,unique,O
new,a,O
repeats,therefore,O
EGF,EGF,O
therefore,likely,O
LDLR,the,O
a,a,O
likely,LRP5,O
The,The,O
encoded,encoded,O
.,.,O
a,new,O
represents,represents,O
;,;,O
of,of,O
",",",",O
LRP5,repeats,O
organization,organization,O
the,LDLR,O
LDLR,LDLR,O
,,
indicating,identical,O
Both,Both,O
are,proteins,O
human,human,O
and,and,O
%,%,O
encoded,encoded,O
of,conservation,O
proteins,are,O
.,.,O
95,indicating,O
LRP5,LRP5,O
a,degree,O
isolated,and,O
identical,95,O
high,a,O
conservation,evolutionary,O
the,the,O
evolutionary,of,O
cDNAs,cDNAs,O
degree,high,O
mature,mature,O
have,have,O
mouse,mouse,O
.,.,O
and,isolated,O
",",",",O
been,been,O
,,
a,a,O
variants,the,O
associated,are,O
with,with,O
with,with,O
and,and,O
tumors,tumors,I
are,E1317Q,O
family,history,O
always,always,O
history,family,O
.,.,O
E1317Q,associated,O
but,not,O
The,Variants,O
",",",",O
colorectal,colorectal,B
I1307K,I1307K,O
not,but,O
APC,APC,B
,,
carcinoma,carcinoma,I
familial,familial,B
mutations,mutations,O
adenomatous,adenomatous,I
gene,the,O
that,that,O
or,hundreds,O
autosomal,autosomal,B
.,.,O
adenomas,adenomas,I
from,results,O
dominant,dominant,I
results,from,O
Classical,Classical,O
-,-,O
the,gene,O
penetrance,penetrance,O
a,a,O
disease,disease,I
),),O
predisposes,to,O
hundreds,predisposes,O
FAP,FAP,B
colorectal,colorectal,B
and,and,I
of,of,O
to,or,O
thousands,thousands,O
polyposis,polyposis,I
(,(,O
is,is,O
and,and,O
high,high,O
APC,APC,B
truncating,truncating,O
that,that,O
in,in,O
,,
of,of,O
3,and,O
5,5,O
line,germ,O
germ,line,O
polyposis,polyposis,I
is,which,O
variant,a,O
attenuated,attenuated,B
which,is,O
adenomatous,adenomatous,I
results,results,O
FAP,FAP,B
.,.,O
APC,APC,B
in,the,O
from,from,O
-,-,O
gene,the,O
the,gene,O
of,of,O
",",",",O
mutations,mutations,O
coli,coli,I
the,in,O
regions,regions,O
and,3,O
A,Variant,O
,,
fewer,fewer,O
FAP,FAP,B
.,.,O
of,classical,O
without,without,O
Attenuated,Attenuated,B
coli,coli,I
colorectal,colorectal,B
" O
multiple O
"," O
multiple O
",O
adenomatous,adenomatous,I
adenomas,adenomas,I
),),O
classical,of,O
polyposis,polyposis,I
patients,Patients,O
phenotype,phenotype,O
have,typically,O
than,than,O
the,the,O
(,(,O
typically,have,O
florid,florid,O
100,100,O
,,
",",",",O
at,a,O
a,at,O
results,phenotype,O
Another,Another,O
mutations,mutations,O
patients,patients,O
the,and,O
adenomas,adenomas,B
loci,or,O
multiple,has,O
",",",",O
group,of,O
their,their,O
variation,variation,O
and,gene,O
with,with,O
gene,the,O
genome,genome,O
.,.,O
from,from,O
",",",",O
the,in,O
of,group,O
elsewhere,elsewhere,O
phenotype,probably,O
in,the,O
APC,APC,B
probably,results,O
in,in,O
or,loci,O
has,multiple,O
no,no,O
locus,locus,O
,,
increased,confers,O
.,.,O
tumors,tumors,I
of,of,O
",",",",O
including,of,O
",",",",O
described,described,O
(,(,O
that,an,O
colorectal,colorectal,B
was,was,O
variant,variant,O
in,in,O
missense,missense,O
of,including,O
however,however,O
an,increased,O
risk,risk,O
a,a,O
Recently,Recently,O
I1307K,I1307K,O
",",",",O
multiple,multiple,O
),),O
APC,APC,B
confers,that,O
",",",",O
Ashkenazim,Ashkenazim,O
adenomas,adenomas,B
,,
for,for,O
codons,1263,O
carcinoma,carcinoma,I
.,.,O
a,a,O
15G,15G,O
of,164,O
have,have,O
-,-,O
-,-,O
),),O
and,and,O
1263,codons,O
1377,exon,O
germ,germ,O
variants,variants,O
adenomas,adenomas,I
APC,APC,B
(,(,O
with,with,O
multiple,multiple,O
gene,the,O
colorectal,colorectal,B
/,/,I
We,We,O
line,line,O
exon,1377,O
patients,patients,O
of,of,O
and,and,I
studied,studied,O
the,gene,O
analyzed,analyzed,O
164,of,O
or,or,I
set,set,O
,,
detected,detected,O
Ashkenazi,descent,O
I1307K,with,O
Three,Three,O
with,the,O
descent,Ashkenazi,O
of,each,O
were,were,O
patients,patients,O
.,.,O
each,of,O
",",",",O
allele,allele,O
the,I1307K,O
,,
individuals,individuals,O
the,the,I
;,;,O
present,in,O
patients,four,O
variant,variant,O
germ,germ,O
a,a,O
line,line,O
-,-,O
missense,missense,O
APC,APC,O
number,number,O
of,of,I
not,not,O
metaplastic,metaplastic,B
was,was,O
one,controls,O
large,unusually,O
these,of,O
.,.,O
in,present,O
colorectum,colorectum,I
polyps,polyps,I
an,an,O
had,had,O
of,of,O
unusually,large,O
E1317Q,E1317Q,O
had,had,O
that,that,O
Four,Patients,O
controls,one,O
of,of,O
of,these,O
,,
increasing,evidence,O
importance,with,O
florid,phenotype,O
the,risk,O
is,there,O
.,.,O
of,development,O
adenomas,adenomas,I
gene,that,O
",",",",O
and,and,O
and,and,I
for,for,O
classical,classical,O
germ,germ,O
the,the,O
population,population,O
There,Is,O
without,without,O
risk,in,O
evidence,increasing,O
but,but,O
that,that,O
colorectal,colorectal,B
multiple,multiple,O
",",",",O
APC,APC,B
-,-,O
of,variants,O
line,line,O
development,of,O
variants,of,O
of,of,O
the,the,O
cancer,cancer,I
in,the,O
FAP,FAP,B
.,.,O
predispose,predispose,O
to,to,O
exist,there,O
the,the,O
possibly,possibly,O
phenotype,florid,O
carcinoma,carcinoma,I
with,importance,O
that,gene,O
colorectal,colorectal,B
general,general,O
there,exist,O
,,
gene,gene,O
.,.,O
the,human,O
congenital,congenital,B
chloride,chloride,I
(,(,O
diarrhea,diarrhea,I
CLD,CLD,B
human,the,O
),),O
of,of,O
structure,genomic,O
Genomic,Structure,O
,,
which,encodes,O
transporter,transporter,O
is,is,O
in,mutations,O
(,(,O
diarrhea,diarrhea,I
mutations,by,O
intestinal,intestinal,O
),),O
CLD,CLD,B
an,an,O
gene,gene,O
by,caused,O
a,a,O
encodes,which,O
anion,anion,O
.,.,O
Congenital,Congenital,B
caused,in,O
chloride,chloride,I
,,
We,We,O
approximately,and,O
organization,organization,O
report,here,O
of,the,O
39kb,approximately,O
.,.,O
here,report,O
comprises,comprises,O
gene,gene,O
CLD,CLD,B
complete,genomic,O
spans,spans,O
the,complete,O
the,of,O
genomic,the,O
",",",",O
exons,exons,O
human,human,O
21,21,O
and,39kb,O
which,which,O
,,
/,/,O
intron,exon,O
conform,conform,O
.,.,O
AG,AG,O
exon,boundaries,O
boundaries,intron,O
to,the,O
/,/,O
GT,GT,O
All,All,O
the,to,O
rule,rule,O
,,
transcription,factor,O
the,putative,O
box,box,O
and,multiple,O
TATA,TATA,O
a,putative,O
multiple,predicts,O
region,region,O
An,Analysis,O
predicts,and,O
.,.,O
promoter,promoter,O
putative,a,O
shows,shows,O
binding,binding,O
analysis,an,O
of,of,O
putative,the,O
factor,transcription,O
sequence,sequence,O
sites,sites,O
,,
from,from,O
genomic,and,O
from,DNA,O
structure,structure,O
-,-,O
controls,and,O
The,The,O
DNA,DNA,O
genomic,genomic,O
and,genomic,O
and,patients,O
DNA,from,O
using,was,O
multiple,multiple,O
several,several,O
including,including,O
patients,controls,O
was,determined,O
libaries,libaries,O
determined,using,O
sources,sources,O
insert,large,O
CLD,CLD,B
large,insert,O
.,.,O
Finnish,Finnish,O
,,
of,of,O
study,study,O
developed,in,O
studies,studies,O
the,disease,O
primers,exon,O
this,this,O
patients,patients,O
.,.,O
in,developed,O
mutation,mutation,O
will,facilitate,O
with,the,O
-,-,O
specific,primers,O
facilitate,will,O
screening,screening,O
disease,with,O
Exon,Specific,O
,,
with,a,O
_,_,O
gene,gene,O
identified,as,O
3,of,O
.,.,O
sequencing,sequencing,O
a,with,O
revealed,RG364P16,O
another,another,O
as,identified,O
similar,similar,O
the,the,O
genomic,genomic,O
PDS,PDS,B
of,of,O
clone,H,O
a,of,O
CLD,CLD,B
the,gene,O
homologous,homologous,O
of,a,O
structure,recently,O
H,clone,O
Pendred,Pendred,B
",",",",O
",",",",O
RG364P16,revealed,O
recently,structure,O
BAC,BAC,O
syndrome,syndrome,I
.,.,O
(,(,O
Genomic,Genomic,O
gene,gene,O
gene,the,O
the,presence,O
highly,highly,O
",",",",O
),),O
presence,the,O
of,3,O
,,
Jews,Jews,O
in,in,O
and,risk,O
.,.,O
a,a,O
allele,APCI1307K,O
based,based,O
-,-,O
Ashkenazi,of,O
risk,allele,O
The,The,O
study,study,O
APCI1307K,and,O
of,Ashkenazi,O
community,community,O
cancer,cancer,B
,,
multiple,intestinal,O
dominant,dominant,I
without,and,O
familial,familial,B
cancer,cancer,I
colorectal,colorectal,B
polyps,polyps,B
and,without,O
development,of,O
penetrant,penetrant,O
disorder,disorder,I
",",",",O
by,by,O
autosomal,autosomal,B
associated,classically,O
are,are,O
FAP,FAP,B
.,.,O
(,(,O
with,with,O
classically,associated,O
",",",",O
APC,in,O
intestinal,multiple,O
),),O
",",",",O
highly,highly,O
polyposis,polyposis,I
of,the,O
intervention,surgical,O
(,(,O
in,APC,O
),),O
adenomatous,adenomatous,I
Mutations,Mutations,O
characterized,characterized,O
a,a,O
CRC,CRC,B
the,development,O
surgical,intervention,O
,,
in,in,O
somatic,somatic,O
.,.,O
a,is,O
and,gene,O
suppressor,suppressor,O
",",",",O
APC,APC,B
tumours,tumours,B
gene,and,O
-,-,O
loss,occurs,O
occurs,loss,O
tumour,tumour,O
is,A,O
,,
to,to,O
T,T,O
and,to,O
somatic,mutation,O
),),O
wild,type,O
to,to,O
unstable,unstable,O
The,The,O
mutation,somatic,O
-,-,O
APC,allele,O
prone,and,O
type,wild,O
A,transversion,O
that,that,O
the,the,O
allele,I1307K,O
sequence,sequence,O
-,-,O
germline,germline,O
homopolymer,a,O
for,responsible,O
transversion,A,O
converts,converts,O
(,(,O
is,is,O
responsible,for,O
to,prone,O
I1307K,APC,O
tract,A8,O
A8,tract,O
.,.,O
-,-,O
genetically,genetically,O
the,the,O
a,homopolymer,O
,,
I1307K,allele,O
allele,I1307K,O
in,found,O
6,in,O
found,6,O
.,.,O
The,The,O
was,was,O
,,
or,family,O
histories,personal,O
with,with,O
and,Jews,O
family,or,O
personal,histories,O
Jews,and,O
CRC,CRC,B
ref,2,O
.,.,O
of,of,O
higher,higher,O
Ashkenazim,Ashkenazim,O
(,(,O
.,.,O
),),O
1,Of,O
2,ref,O
%,%,O
of,unselected,O
unselected,1,O
proportions,proportions,O
Ashkenazi,Ashkenazi,O
of,of,O
,,
a,volunteers,O
genotyped,we,O
081,5,O
volunteers,in,O
in,a,O
evaluate,evaluate,O
.,.,O
",",",",O
of,of,O
role,role,O
5,081,O
cancer,cancer,B
To,To,O
",",",",O
Ashkenazi,Ashkenazi,O
in,I1307K,O
community,survey,O
survey,community,O
the,the,O
I1307K,in,O
we,genotyped,O
,,
between,genotyped,O
colorectal,colorectal,B
other,other,I
relatives,relatives,O
I1307K,I1307K,O
were,were,O
breast,breast,I
carriers,carriers,O
",",",",I
developing,developing,O
and,and,I
-,-,O
first,degree,O
.,.,O
and,non,O
carriers,carriers,O
-,-,O
compared,compared,O
genotyped,between,O
of,of,O
cancers,cancers,I
their,and,O
degree,first,O
Risk,Risk,O
and,their,O
non,and,O
,,
DNA,analysis,O
and,and,O
.,.,O
both,both,O
Sperm,DNA,O
FRDA,FRDA,B
gene,in,O
a,a,O
carrier,carrier,O
the,gene,O
in,sperm,O
mitotic,mitotic,O
analysis,in,O
suggests,suggests,O
Friedreich,Friedreich,B
expansion,expansion,O
in,the,O
ataxia,ataxia,I
meiotic,meiotic,O
premutation,premutation,O
,,
an,an,O
a,a,O
is,is,O
caused,by,O
FRDA,FRDA,B
Friedreich,Friedreich,B
intron,repeat,O
the,gene,O
of,of,O
trinucleotide,trinucleotide,O
1,1,O
repeat,intron,O
by,usually,O
of,of,O
GAA,GAA,O
.,.,O
ataxia,ataxia,I
gene,the,O
in,in,O
usually,caused,O
expansion,expansion,O
,,
of,premutation,O
triplet,triplet,O
or,or,O
has,allele,O
100,of,O
a,occasionally,O
",",",",O
repeats,repeats,O
Occasionally,A,O
from,from,O
arise,to,O
premutation,100,O
fully,fully,O
less,less,O
found,been,O
.,.,O
a,a,O
expanded,expanded,O
allele,has,O
been,found,O
to,arise,O
,,
sperm,sperm,O
have,have,O
a,premutation,O
premutation,carrier,O
examined,examined,O
the,the,O
carrier,a,O
DNA,of,O
of,DNA,O
.,.,O
We,We,O
,,
showed,showed,O
and,one,O
one,one,O
allele,allele,O
normal,normal,O
This,Mans,O
.,.,O
100,repeats,O
of,of,O
one,and,O
DNA,leucocyte,O
leucocyte,this,O
mans,DNA,O
allele,allele,O
approximately,approximately,O
repeats,100,O
,,
expanded,expanded,O
allele,allele,O
a,tight,O
showed,showed,O
tight,a,O
size,size,O
range,range,O
His,Sperm,O
trinucleotide,repeats,O
of,of,O
approximately,approximately,O
in,in,O
320,320,O
on,centering,O
repeats,trinucleotide,O
sperm,his,O
centering,on,O
a,a,O
.,.,O
an,an,O
,,
son,son,O
repeat,has,O
.,.,O
of,of,O
His,His,O
540,540,O
1040,and,O
and,1040,O
sizes,repeat,O
affected,affected,O
has,sizes,O
,,
during,meiosis,O
meiosis,during,O
These,These,O
first,first,O
occurs,occurs,O
by,by,O
suggest,expansion,O
",",",",O
a,mitotic,O
stages,two,O
in,in,O
expansion,that,O
followed,followed,O
that,suggest,O
two,stages,O
data,data,O
expansion,expansion,O
.,.,O
second,a,O
mitotic,second,O
the,the,O
,,
We,We,O
carrier,premutation,O
transmissions,transmissions,O
with,with,O
.,.,O
",",",",O
",",",",O
informative,all,O
affected,to,O
child,child,O
all,informative,O
carrier,father,O
the,the,O
the,carrier,O
in,in,O
expansion,expansion,O
the,the,O
show,that,O
size,size,O
also,also,O
premutation,the,O
of,notable,O
that,show,O
to,affected,O
notable,exception,O
father,carrier,O
decreases,decreases,O
exception,of,O
.,.,O
,,
leukodystrophy,leukodystrophy,I
mutation,mutation,O
not,A,O
cause,not,O
does,cause,O
.,.,O
A,does,O
metachromatic,metachromatic,B
of,of,O
The,The,O
R496H,R496H,O
arylsulfatase,arylsulfatase,O
,,
MLD,MLD,B
(,(,O
.,.,O
activity,ARSA,O
leukodystrophy,leukodystrophy,I
of,of,I
ARSA,enzyme,O
metachromatic,metachromatic,B
),),O
arylsulfatase,arylsulfatase,I
Deficiency,Deficiency,B
causes,causes,O
enzyme,activity,O
),),O
(,(,O
A,A,I
,,
responsible,for,O
MLD,MLD,B
mutations,mutations,O
gene,gene,O
been,have,O
.,.,O
ARSA,ARSA,O
for,responsible,O
identified,identified,O
number,number,O
have,been,O
of,of,O
A,A,O
,,
the,R496H,O
",",",",O
1997,1997,O
.,.,O
.,.,O
R496H,the,O
),),O
proposed,was,O
to,to,O
cause,be,O
was,proposed,O
be,a,O
Draghia,Draghia,O
MLD,MLD,B
mutation,mutation,O
al,al,O
a,cause,O
",",",",O
et,et,O
of,of,O
(,(,O
ARSA,ARSA,O
Recently,Recently,O
of,of,O
,,
in,in,O
found,this,O
at,mutation,O
a,at,O
f,f,O
have,have,O
African,African,O
09,0,O
=,=,O
high,high,O
.,.,O
the,the,O
=,=,O
American,population,O
(,(,O
and,and,O
frequency,frequency,O
n,n,O
mutation,R496H,O
.,.,O
",",",",O
relatively,relatively,O
We,We,O
),),O
subjects,subjects,O
0,09,O
mutation,a,O
population,American,O
61,61,O
investigated,investigated,O
an,an,O
this,found,O
R496H,mutation,O
,,
without,without,O
and,and,O
was,was,O
.,.,O
with,subjects,O
be,normal,O
mutation,mutation,O
R496H,the,O
activity,activity,O
the,R496H,O
to,to,O
in,in,O
subjects,with,O
normal,be,O
found,found,O
and,determined,O
determined,and,O
enzyme,enzyme,O
ARSA,ARSA,O
The,The,O
,,
ARSA,ARSA,O
not,not,O
of,of,O
of,of,O
is,is,O
not,negatively,O
activity,the,O
is,is,O
therefore,concluded,O
the,R496H,O
that,that,O
does,does,O
of,cause,O
negatively,not,O
the,activity,O
a,a,O
concluded,therefore,O
It,It,O
ARSA,ARSA,O
cause,of,O
MLD,MLD,B
R496H,mutation,O
and,and,O
influence,influence,O
mutation,the,O
,,
carcinoma,carcinoma,I
in,lines,O
Down,Down,O
type,transgenes,O
renal,renal,B
von,von,B
regulation,regulation,O
Hippel,Hippel,I
-,-,O
by,by,O
cell,cell,I
carbonic,carbonic,O
wild,type,O
cell,in,O
transmembrane,transmembrane,O
transgenes,wild,O
.,.,O
-,-,O
anhydrases,anhydrases,O
of,of,O
Lindau,Lindau,I
-,-,I
lines,cell,O
,,
von,von,B
Lindau,Lindau,I
-,-,O
mediated,mediated,O
stably,stably,O
expressing,transgenes,O
carcinoma,carcinoma,I
transgenes,expressing,O
cell,lines,O
-,-,O
with,transfected,O
),),O
transfected,with,O
we,used,O
.,.,O
involved,genes,O
lines,cell,O
discover,involved,O
renal,renal,B
-,-,O
",",",",O
used,we,O
type,type,O
genes,discover,O
carcinogenesis,carcinogenesis,O
-,-,I
VHL,VHL,O
(,(,O
To,To,O
VHL,VHL,B
in,in,O
wild,wild,O
cell,cell,I
Hippel,Hippel,I
,,
alpha,alpha,O
lines,several,O
identified,lines,O
genes,expressed,O
scale,large,O
gene,gene,O
anhydrase,anhydrase,O
technology,technology,O
.,.,O
",",",",O
including,an,O
Large,Scale,O
these,these,O
display,display,O
expressed,genes,O
termed,CA12,O
carbonic,carbonic,O
differential,differential,O
an,including,O
differentially,differentially,O
RNA,RNA,O
to,to,O
several,identified,O
CA12,termed,O
applied,applied,O
-,-,O
",",",",O
cell,cell,O
,,
-,-,O
The,Deduced,O
catalytic,intact,O
the,the,O
pass,pass,O
deduced,protein,O
CA,CA,O
a,was,O
.,.,O
apparently,apparently,O
classified,as,O
was,classified,O
intact,catalytic,O
module,module,O
sequence,sequence,O
protein,the,O
CA,CA,O
one,one,O
extracellular,extracellular,O
in,domain,O
an,an,O
as,a,O
possessing,possessing,O
transmembrane,transmembrane,O
domain,in,O
,,
-,-,O
gene,CA12,O
in,the,O
type,strongly,O
overexpression,the,O
CA12,gene,O
the,of,O
carcinoma,carcinoma,I
strongly,type,O
of,the,O
.,.,O
parental,parental,O
VHL,VHL,B
renal,renal,B
the,in,O
cell,cell,I
Reintroduced,Reintroduced,O
lines,lines,O
the,overexpression,O
wild,wild,O
cell,cell,O
inhibited,inhibited,O
,,
domain,catalytic,O
.,.,O
obtained,with,O
CA,transmembrane,O
intact,intact,O
another,encoding,O
CA9,CA9,O
with,obtained,O
were,were,O
results,similar,O
with,with,O
encoding,another,O
",",",",O
transmembrane,CA,O
an,an,O
catalytic,domain,O
Similar,Results,O
,,
effectively,could,O
could,effectively,O
CA9,regulate,O
elongin,elongin,O
alone,domain,O
protein,protein,O
of,of,O
binding,binding,O
expression,expression,O
VHL,VHL,B
both,although,O
the,the,O
of,of,O
.,.,O
the,the,O
CA12,CA12,O
Although,Both,O
domain,alone,O
",",",",O
regulate,CA9,O
contribute,to,O
regulation,regulation,O
domains,domains,O
to,contribute,O
expression,expression,O
,,
.,.,O
mapped,mapped,O
and,and,O
loci,to,O
bands,bands,O
15q22,15q22,O
to,loci,O
17q21,and,O
We,We,O
and,17q21,O
CA12,CA12,O
chromosome,chromosome,O
CA9,CA9,O
,,
",",",",O
in,in,O
amplification,amplification,O
human,some,O
cancers,cancers,B
prone,to,O
.,.,O
to,prone,O
2,respectively,O
regions,regions,O
respectively,2,O
some,human,O
,,
define,define,O
and,and,O
of,of,O
cancer,cancer,B
CA,CA,O
CA,IX,O
XII,XII,O
the,role,O
potential,potential,O
needed,needed,O
microenvironment,its,O
experiments,experiments,O
regulation,regulation,O
in,in,O
and,microenvironment,O
.,.,O
pH,pH,O
are,are,O
its,and,O
to,to,O
the,enzymes,O
role,the,O
growth,growth,O
in,the,O
enzymes,in,O
impact,impact,O
IX,CA,O
Additional,Additional,O
extracellular,extracellular,O
on,on,O
the,the,O
cell,cell,O
of,of,O
,,
gene,gene,O
is,protein,O
mutated,mutated,O
transmembrane,transmembrane,O
A,A,O
atrophy,atrophy,I
mellitus,mellitus,I
syndrome,syndrome,I
),),O
protein,is,O
Wolfram,Wolfram,B
with,and,O
.,.,O
diabetes,diabetes,B
encoding,a,O
optic,optic,B
patients,in,O
and,with,O
(,(,O
a,encoding,O
in,patients,O
,,
young,young,O
Wolfram,Wolfram,B
recessive,recessive,I
diabetes,diabetes,I
insulin,insulin,B
OMIM,222300,O
immune,immune,O
is,an,O
syndrome,syndrome,I
atrophy,atrophy,I
dependent,dependent,I
defined,by,O
onset,onset,O
-,-,I
optic,optic,B
an,is,O
222300,OMIM,O
;,;,O
neurodegenerative,neurodegenerative,I
progressive,and,O
(,(,O
and,progressive,O
mellitus,mellitus,I
non,non,O
-,-,O
autosomal,autosomal,B
by,defined,O
disorder,disorder,I
.,.,O
WFS,WFS,B
),),O
-,-,O
,,
to,linkage,O
Linkage,To,O
on,on,O
4p,4p,O
five,in,O
families,five,O
confirmed,was,O
markers,markers,O
chromosome,chromosome,O
.,.,O
in,families,O
was,confirmed,O
,,
to,a,O
",",",",O
of,of,O
the,the,O
/,/,O
BAC,to,O
.,.,O
contig,P1,O
of,meiotic,O
recombinants,of,O
a,BAC,O
was,gene,O
WFS,WFS,B
250,than,O
kb,kb,O
than,250,O
localized,localized,O
On,The,O
less,less,O
associated,associated,O
P1,contig,O
disease,disease,O
meiotic,recombinants,O
basis,basis,O
haplotypes,haplotypes,O
gene,was,O
-,-,O
and,and,O
the,on,O
,,
",",",",O
disease,phenotype,O
these,these,O
a,a,O
protein,transmembrane,O
all,affected,O
with,with,O
a,a,O
and,families,O
six,in,O
families,and,O
in,in,O
putative,putative,O
WFS1,WFS1,O
gene,novel,O
WFS,WFS,B
mutations,mutations,O
Mutations,Mutations,O
.,.,O
found,found,O
in,in,O
the,disease,O
were,were,O
(,(,O
associated,associated,O
encoding,encoding,O
in,six,O
individuals,individuals,O
novel,gene,O
phenotype,the,O
transmembrane,protein,O
),),O
affected,all,O
were,were,O
,,
-,-,O
neurons,and,O
beta,islet,O
in,function,O
function,in,O
.,.,O
and,neurons,O
.,.,O
survival,survival,O
islet,beta,O
WFS1,WFS1,O
appears,to,O
of,of,O
cells,cells,O
to,appears,O
,,
.,.,O
in,in,O
cells,and,O
tumor,tumor,B
interaction,interaction,O
BRCA2,and,O
between,between,O
BRCA1,the,O
and,BRCA1,O
products,products,O
the,the,O
suppressor,suppressor,O
meiotic,cells,O
and,mitotic,O
mitotic,meiotic,O
Stable,Stable,O
genes,genes,O
the,BRCA2,O
of,of,O
,,
cancer,cancer,I
hRAD51,hRAD51,O
BRCA2,and,O
and,and,O
and,and,I
products,products,O
breast,breast,B
for,account,O
and,BRCA2,O
account,for,O
onset,onset,O
",",",",O
or,or,I
familial,early,O
cases,of,O
early,familial,O
of,most,O
interact,with,O
encode,encode,O
each,each,O
with,interact,O
ovarian,ovarian,I
/,/,I
that,that,O
BRCA1,BRCA1,O
.,.,O
most,cases,O
,,
and,on,O
foci,foci,O
presented,presented,O
in,in,O
Results,Results,O
in,in,O
here,here,O
in,coexist,O
cells,somatic,O
of,of,O
a,a,O
on,the,O
BRCA2,BRCA2,O
subnuclear,subnuclear,O
synaptonemal,developing,O
the,and,O
elements,elements,O
.,.,O
BRCA1,BRCA1,O
coexist,in,O
and,and,O
colocalize,colocalize,O
that,show,O
and,and,O
developing,synaptonemal,O
complexes,complexes,O
somatic,cells,O
complex,biochemical,O
biochemical,complex,O
show,that,O
axial,axial,O
,,
phase,S,O
of,of,O
irradiation,or,O
following,following,O
hydroxyurea,hydroxyurea,O
BRCA1,like,O
UV,irradiation,O
RAD51,BRCA2,O
or,UV,O
relocates,relocates,O
Like,And,O
exposure,exposure,O
.,.,O
and,RAD51,O
+,+,O
S,phase,O
replication,replication,O
sites,sites,O
to,to,O
PCNA,PCNA,O
to,to,O
cells,cells,O
",",",",O
BRCA2,BRCA1,O
,,
",",",",O
recombination,recombination,O
.,.,O
and,BRCA2,O
pathway,pathway,O
Thus,BRCA1,O
participate,participate,O
",",",",O
",",",",O
homologous,or,O
break,break,O
double,double,O
BRCA2,and,O
BRCA1,thus,O
associated,associated,O
activation,activation,O
-,-,O
the,the,O
in,in,O
and,and,O
/,/,O
a,a,O
(,(,O
or,homologous,O
with,with,O
s,s,O
together,together,O
repair,repair,O
),),O
of,of,O
strand,strand,O
,,
cancer,cancer,I
of,majority,O
majority,of,O
.,.,O
pathway,pathway,O
in,the,O
cases,cases,O
be,be,O
hereditary,hereditary,B
the,phenomenon,O
of,this,O
breast,breast,I
/,/,I
may,may,O
phenomenon,in,O
and,and,I
a,a,O
Dysfunction,Of,O
.,.,O
ovarian,ovarian,I
this,dysfunction,O
general,general,O
or,or,I
of,of,O
,,
splicing,and,O
hydroxylase,hydroxylase,O
mRNA,mRNA,O
gene,gene,O
:,:,O
CYP27,CYP27,O
its,effects,O
the,the,O
-,-,O
.,.,O
and,splicing,O
enzyme,enzyme,O
in,in,O
novel,a,O
),),O
A,Novel,O
27,sterol,O
sterol,27,O
mutation,mutation,O
-,-,O
on,on,O
activity,activity,O
effects,its,O
(,(,O
Arg362Ser,Arg362Ser,O
pre,pre,O
,,
C,to,O
gene,gene,O
with,patient,O
a,a,O
cerebrotendinous,cerebrotendinous,B
by,identified,O
identified,by,O
CYP27,CYP27,O
mutation,A,O
sterol,27,O
.,.,O
gene,hydroxylase,O
the,the,O
xanthomatosis,xanthomatosis,I
patient,with,O
novel,a,O
sequencing,sequencing,O
hydroxylase,gene,O
(,(,O
to,C,O
from,from,O
),),O
CTX,CTX,B
products,products,O
CYP27,CYP27,O
-,-,O
(,(,O
was,was,O
27,sterol,O
in,mutation,O
amplified,amplified,O
),),O
A,in,O
A,Novel,O
,,
of,of,O
-,-,O
residue,residue,O
expression,expression,O
(,(,O
binding,binding,O
CGT,CGT,O
and,responsible,O
to,362Arg,O
changed,changed,O
by,by,O
362Arg,362Arg,O
into,cDNA,O
was,and,O
confirmed,confirmed,O
cDNA,into,O
27,27,O
sterol,the,O
mutation,mutation,O
the,the,O
in,in,O
for,for,O
362Ser,362Ser,O
adrenodoxin,adrenodoxin,O
mutant,mutant,O
362Ser,362Ser,O
The,The,O
deficiency,deficiency,O
),),O
hydroxylase,hydroxylase,O
362Arg,to,O
.,.,O
cofactor,cofactor,O
1,cells,O
to,to,O
-,-,O
",",",",O
activity,activity,O
the,sterol,O
AGT,AGT,O
cells,1,O
",",",",O
responsible,was,O
as,as,O
COS,COS,O
,,
52,52,O
of,of,O
Quantitative,Quantitative,O
analysis,showed,O
patient,the,O
represented,represented,O
in,mRNA,O
showed,analysis,O
the,the,O
gene,gene,O
CYP27,CYP27,O
.,.,O
the,patient,O
that,that,O
mRNA,in,O
expression,expression,O
,,
5,5,O
.,.,O
of,of,O
%,%,O
level,normal,O
normal,the,O
the,level,O
,,
the,the,O
of,the,O
position,position,O
exon,6,O
site,splice,O
the,normal,O
.,.,O
splicing,splicing,O
alternative,alternative,O
-,-,O
As,As,O
gene,gene,O
exon,exon,O
6,6,O
6,exon,O
that,hypothesized,O
-,-,O
in,efficiency,O
which,elsewhere,O
",",",",O
occurred,occurred,O
hypothesized,that,O
in,decreased,O
patient,the,O
mutation,mutation,O
exon,exon,O
of,of,O
(,(,O
in,in,O
6,6,O
elsewhere,which,O
mutation,the,O
nucleotide,nucleotide,O
splice,site,O
may,may,O
efficiency,in,O
partially,partially,O
6,6,O
we,we,O
transcript,transcript,O
resulted,resulted,O
affect,affect,O
normal,the,O
the,of,O
),),O
the,the,O
intron,intron,O
and,and,O
penultimate,penultimate,O
",",",",O
the,mutation,O
cause,cause,O
2,2,O
at,at,O
of,of,O
splicing,splicing,O
decreased,in,O
the,patient,O
,,
cryptic,cryptic,O
-,-,O
at,at,O
the,from,O
from,the,O
bp,bp,O
Transfection,Of,O
end,end,O
of,transfection,O
site,splice,O
constructed,constructed,O
5,5,O
COS,COS,O
88,88,O
into,into,O
splice,site,O
3,3,O
for,for,O
an,an,O
alternatively,species,O
exon,exon,O
species,alternatively,O
cells,1,O
activated,activated,O
the,the,O
a,a,O
",",",",O
",",",",O
spliced,spliced,O
responsible,responsible,O
of,of,O
1,cells,O
upstream,upstream,O
was,was,O
mutant,mutant,O
6,6,O
the,the,O
that,that,O
minigenes,with,O
without,without,O
with,minigenes,O
or,or,O
minigene,minigene,O
.,.,O
mutation,mutation,O
confirmed,confirmed,O
mRNA,mRNA,O
,,
of,of,O
CYP27,CYP27,O
splicing,splicing,O
that,that,O
6,6,O
the,the,O
penultimate,penultimate,O
pre,pre,O
27,27,I
partially,leads,O
data,data,O
in,in,I
gene,gene,O
activity,activity,I
sterol,sterol,I
-,-,I
hydroxylase,hydroxylase,I
to,alternative,O
alternative,to,O
",",",",O
mutation,A,O
of,the,O
Our,Our,O
not,gene,O
gene,not,O
the,of,O
C,C,O
deficiency,deficiency,B
nucleotide,nucleotide,O
the,the,O
but,but,O
mRNA,mRNA,O
.,.,O
the,only,O
also,also,O
exon,of,O
the,at,O
-,-,O
causes,causes,O
to,to,O
leads,partially,O
suggest,suggest,O
only,the,O
of,exon,O
the,the,I
at,the,O
A,mutation,O
,,
effects,on,O
the,the,O
mRNA,splicing,O
knowledge,knowledge,O
regarding,effects,O
position,a,O
site,site,O
our,to,O
splice,splice,O
of,of,O
2,2,O
splicing,pre,O
To,Our,O
a,a,O
-,-,O
on,regarding,O
pre,mRNA,O
report,report,O
of,position,O
this,this,O
5,5,O
is,is,O
at,mutation,O
a,of,O
-,-,O
.,.,O
",",",",O
first,first,O
mutation,at,O
the,the,O
,,
patients,in,O
.,.,O
classical,classical,O
in,in,O
ATM,ATM,O
the,the,O
in,patients,O
population,population,O
Dutch,Dutch,O
telangiectasia,telangiectasia,I
ataxia,ataxia,B
-,-,I
germline,germline,O
mutations,mutations,O
,,
for,for,O
mutations,mutations,O
-,-,I
(,(,O
.,.,O
responsible,are,O
ataxia,ataxia,B
in,the,O
disorder,disorder,I
T,T,I
telangiectasia,telangiectasia,I
A,A,B
are,responsible,O
-,-,I
Germline,Germline,O
recessive,recessive,I
),),O
autosomal,autosomal,B
the,the,O
ATM,in,O
gene,gene,O
the,ATM,O
,,
some,including,O
mutation,mutation,O
determined,determined,O
as,as,O
T,T,I
have,have,O
A,A,B
immigrant,some,O
study,we,O
patients,patients,O
12,12,O
classical,classical,O
ATM,ATM,O
our,our,O
origin,Dutch,O
spectrum,spectrum,O
",",",",O
-,-,I
populations,populations,O
we,study,O
ethnic,origin,O
",",",",O
well,well,O
",",",",O
.,.,O
19,in,O
Dutch,ethnic,O
as,as,O
of,of,O
the,the,O
including,immigrant,O
in,19,O
In,In,O
,,
76,76,O
detection,detection,O
test,test,O
and,and,O
PTT,and,O
compared,compared,O
%,%,O
of,of,O
method,method,O
protein,truncation,O
.,.,O
),),O
fingerprinting,fingerprinting,O
respectively,respectively,O
Both,Both,O
the,the,O
were,were,O
endonuclease,endonuclease,O
",",",",O
truncation,protein,O
the,the,O
efficiency,efficiency,O
%,%,O
their,their,O
and,and,O
used,used,O
(,(,O
restriction,restriction,O
(,(,O
mutations,the,O
the,mutations,O
),),O
and,PTT,O
60,60,O
for,for,O
",",",",O
identifying,identifying,O
REF,REF,O
,,
to,be,O
compound,heterozygote,O
patients,patients,O
found,to,O
Most,Most,O
be,found,O
were,were,O
heterozygote,compound,O
.,.,O
,,
.,.,O
were,not,O
were,distinct,O
",",",",O
of,which,O
previously,reported,O
not,were,O
reported,previously,O
10,10,O
Seventeen,Seventeen,O
distinct,were,O
which,of,O
mutations,mutations,O
,,
are,are,O
frequently,frequently,O
small,small,O
deletions,point,O
splice,splice,O
sites,sites,O
affecting,affecting,O
mutations,mutations,O
or,deletions,O
point,or,O
.,.,O
Mutations,Mutations,O
,,
16,a,O
Moreover,Moreover,O
",",",",O
.,.,O
a,16,O
,,
two,two,O
end,end,O
of,the,O
3,3,O
a,likely,O
most,most,O
kb,7,O
the,of,O
deletion,deletion,O
result,result,O
.,.,O
was,was,O
the,of,O
between,between,O
LINE,LINE,O
-,-,O
likely,a,O
identified,identified,O
recombination,of,O
of,the,O
of,recombination,O
",",",",O
elements,elements,O
7,kb,O
genomic,genomic,O
",",",",O
gene,gene,O
,,
found,mutation,O
Turkish,was,O
mutation,mutation,O
to,be,O
A,A,B
was,individuals,O
mutation,identified,O
be,to,O
-,-,I
in,in,O
",",",",O
described,described,O
T,T,I
A,A,B
founder,founder,O
identified,found,O
most,frequently,O
T,T,I
The,The,O
Turkish,Turkish,O
previously,previously,O
three,three,O
individuals,Turkish,O
.,.,O
a,a,O
-,-,I
unrelated,unrelated,O
",",",",O
frequently,most,O
,,
presence,the,O
in,frequency,O
relatively,small,O
The,Presence,O
population,ethnic,O
frequency,in,O
indicate,indicate,O
carrier,carrier,O
mutation,founder,O
in,in,O
such,communities,O
a,a,O
a,a,O
founder,mutation,O
small,relatively,O
Western,could,O
among,among,O
Europe,Western,O
high,high,O
groups,groups,O
could,Europe,O
.,.,O
of,of,O
communities,such,O
ethnic,population,O
,,
could,effect,O
Dutch,of,O
effect,could,O
no,however,O
patients,in,O
.,.,O
identified,be,O
",",",",O
be,identified,O
ethnic,ethnic,O
",",",",O
founder,founder,O
In,Patients,O
however,no,O
of,Dutch,O
origin,origin,O
significant,significant,O
,,
the,the,O
including,including,O
of,splice,O
phenotype,the,O
.,.,O
the,phenotype,O
had,mutations,O
observed,heterogeneity,O
-,-,O
no,no,O
heterogeneity,genetic,O
reflection,reflection,O
high,percentage,O
genetic,observed,O
site,site,O
relative,relative,O
on,on,O
percentage,high,O
The,The,O
mutations,had,O
splice,of,O
,,
T,T,I
cellular,cellular,O
A,A,B
increased,and,O
-,-,I
.,.,O
All,All,O
and,increased,O
radioresistant,radioresistant,O
classical,manifested,O
DNA,DNA,O
patients,classical,O
manifested,patients,O
synthesis,synthesis,O
,,
COL4A4,COL4A4,O
syndrome,syndrome,I
recessive,recessive,I
and,of,O
genomic,of,O
causing,causing,O
the,the,O
of,structure,O
Determination,Of,O
Alport,Alport,I
novel,mutations,O
of,and,O
the,the,O
of,determination,O
.,.,O
mutations,novel,O
gene,gene,O
autosomal,autosomal,B
structure,genomic,O
,,
",",",",O
or,COL4A3,O
syndrome,syndrome,I
alpha4,alpha4,O
.,.,O
and,associated,O
mutations,mutations,O
encode,which,O
membrane,membrane,I
COL4A3,or,O
hematuric,hematuric,B
basement,basement,I
type,type,O
recessive,recessive,I
alpha3,the,O
Autosomal,Autosomal,B
progressive,characterized,O
the,COL4A4,O
which,encode,O
Alport,Alport,I
is,is,O
in,in,O
collagen,IV,O
chains,respectively,O
",",",",O
the,alpha3,O
IV,collagen,O
respectively,chains,O
gene,gene,O
a,a,O
abnormalities,abnormalities,I
associated,and,O
COL4A4,the,O
by,progressive,O
with,with,O
characterized,by,O
glomerular,glomerular,B
and,and,O
the,the,O
either,either,O
glomerulonephritis,glomerulonephritis,I
,,
the,the,O
been,has,O
screening,screening,O
hampered,hampered,O
the,the,O
genes,been,O
.,.,O
of,genomic,O
by,by,O
structure,lack,O
To,Date,O
in,in,O
information,information,O
genomic,structure,O
",",",",O
mutation,mutation,O
lack,of,O
has,genes,O
date,to,O
two,two,O
,,
10,10,O
gene,gene,O
report,report,O
Alport,Alport,I
exons,the,O
the,the,O
detection,detection,O
",",",",O
comprehensive,comprehensive,O
eight,patients,O
complete,complete,O
COL4A4,the,O
",",",",O
here,here,O
syndrome,syndrome,I
the,the,O
recessive,recessive,I
autosomal,autosomal,B
characterization,of,O
.,.,O
the,of,O
mutations,in,O
with,diagnosed,O
We,We,O
gene,gene,O
and,and,O
patients,eight,O
a,a,O
of,of,O
the,48,O
48,exons,O
screen,screen,O
of,COL4A4,O
in,mutations,O
of,characterization,O
subsequent,subsequent,O
diagnosed,with,O
novel,novel,O
,,
is,is,O
.,.,O
heterozygous,carriers,O
in,in,O
a,a,O
that,domain,O
we,we,O
",",",",O
to,alanine,O
",",",",O
silent,apparently,O
apparently,silent,O
carriers,in,O
domain,collagenous,O
11,11,O
Furthermore,Furthermore,O
in,in,O
the,the,O
glycine,to,O
identified,identified,O
in,heterozygous,O
substitution,substitution,O
collagenous,that,O
the,the,O
alanine,glycine,O
,,
control,individual,O
substitution,substitution,O
in,one,O
%,%,O
glycine,this,O
of,5,O
this,glycine,O
.,.,O
",",",",O
individuals,individuals,O
5,all,O
and,and,O
individual,control,O
one,in,O
all,of,O
control,control,O
homozygous,homozygous,O
for,for,O
,,
in,in,O
obvious,obvious,O
is,not,O
There,There,O
not,that,O
has,has,O
been,no,O
homozygous,individuals,O
of,a,O
previous,previous,O
.,.,O
with,with,O
any,any,O
no,been,O
phenotype,phenotype,O
individuals,homozygous,O
substitution,is,O
glycine,substitution,O
a,of,O
finding,finding,O
associated,associated,O
that,glycine,O
,,
French,French,O
and,and,I
Founder,BRCA1,O
in,in,O
and,and,O
families,Canadian,O
cancer,cancer,I
BRCA2,mutations,O
ovarian,ovarian,I
breast,breast,B
BRCA1,founder,O
mutations,BRCA2,O
Canadian,families,O
.,.,O
,,
/,/,I
in,BRCA2,O
We,Have,O
ovarian,ovarian,I
Canadian,Canadian,O
and,families,O
four,identified,O
cancer,cancer,I
BRCA2,in,O
Quebec,from,O
in,in,O
identified,four,O
",",",",O
breast,breast,B
the,the,O
genes,BRCA1,O
French,French,O
breast,breast,B
.,.,O
BRCA1,genes,O
mutations,mutations,O
from,Quebec,O
cancer,cancer,I
breast,breast,B
of,each,O
have,we,O
-,-,O
susceptibility,susceptibility,O
cancer,cancer,I
families,and,O
each,of,O
and,and,O
",",",",O
,,
for,the,O
",",",",O
identify,identify,O
French,ascertained,O
cancer,cancer,B
Canadian,families,O
these,of,O
examined,we,O
the,for,O
ascertained,French,O
families,Canadian,O
mutations,mutations,O
we,examined,O
of,these,O
distribution,distribution,O
eight,eight,O
effects,founder,O
founder,effects,O
independently,independently,O
To,To,O
.,.,O
,,
found,41,O
were,found,O
of,of,O
Mutations,Mutations,O
in,were,O
97,97,O
41,in,O
families,families,O
.,.,O
,,
Six,Six,O
.,.,O
observed,at,O
of,eight,O
eight,of,O
mutations,were,O
were,mutations,O
least,least,O
at,observed,O
twice,twice,O
,,
mutation,mutation,O
by,the,O
The,The,O
most,most,O
followed,followed,O
BRCA2,BRCA2,O
",",",",O
mutation,found,O
was,was,O
the,the,O
common,common,O
mutation,8765delAG,O
found,mutation,O
C4446T,C4446T,O
8765delAG,mutation,O
.,.,O
BRCA1,BRCA1,O
the,by,O
,,
families,identified,O
41,41,O
a,a,O
of,of,O
",",",",O
28,28,O
these,these,O
were,were,O
have,have,O
.,.,O
mutations,mutations,O
to,to,O
mutation,mutation,O
found,found,O
Together,Together,O
identified,families,O
in,in,O
,,
18,was,O
BRCA1,BRCA1,O
mutations,mutations,O
of,of,O
detection,of,O
four,four,O
of,any,O
.,.,O
any,detection,O
the,the,O
odds,odds,O
was,18,O
of,of,O
The,The,O
,,
in,the,O
also,also,O
7x,7x,O
the,family,O
one,one,O
more,or,O
of,cases,O
present,present,O
cases,of,O
if,greater,O
.,.,O
or,more,O
were,were,O
family,in,O
ovarian,ovarian,B
cancer,cancer,I
greater,if,O
,,
BRCA2,mutations,O
The,Odds,O
detection,of,O
four,four,O
the,the,O
odds,the,O
of,of,O
was,5,O
any,any,O
.,.,O
of,detection,O
mutations,BRCA2,O
of,of,O
5,was,O
,,
the,family,O
family,the,O
least,least,O
3x,Greater,O
breast,breast,B
at,at,O
if,if,O
in,of,O
of,in,O
there,there,O
were,were,O
greater,3x,O
cancer,cancer,I
five,cases,O
.,.,O
cases,five,O
,,
was,age,O
of,of,O
of,presence,O
36,years,O
a,a,O
years,of,O
presence,of,O
mutations,mutations,O
of,case,O
case,36,O
breast,breast,B
predictive,strongly,O
of,of,O
of,of,O
cancer,cancer,I
presence,presence,O
Interestingly,The,O
the,the,O
.,.,O
eight,eight,O
screened,screened,O
age,was,O
",",",",O
any,any,O
<,<,O
the,the,O
strongly,predictive,O
the,interestingly,O
,,
were,alleles,O
families,families,O
similar,similar,O
",",",",O
the,the,O
.,.,O
from,mutation,O
mutation,a,O
be,be,O
the,the,O
",",",",O
of,of,O
by,descent,O
that,indicating,O
population,founder,O
haplotypes,haplotypes,O
mutant,mutant,O
in,mutation,O
shared,shared,O
a,in,O
descent,by,O
for,for,O
to,to,O
same,same,O
Carriers,Carriers,O
founder,population,O
likely,likely,O
the,the,O
identical,identical,O
indicating,that,O
mutation,from,O
",",",",O
alleles,were,O
different,different,O
,,
BRCA2,and,O
of,identification,O
cancer,cancer,I
will,will,O
BRCA1,BRCA2,O
/,/,I
.,.,O
common,common,O
families,and,O
identification,of,O
detection,in,O
breast,breast,B
in,detection,O
carrier,facilitate,O
mutations,mutations,O
facilitate,carrier,O
cancer,cancer,I
The,The,O
breast,breast,B
ovarian,ovarian,I
and,families,O
French,French,O
and,BRCA1,O
Canadian,Canadian,O
,,
in,in,O
?,?,O
impairment,impairment,I
Dp71,Dp71,O
Duchenne,Duchenne,B
to,to,O
cognitive,cognitive,B
and,and,O
brain,brain,O
muscular,muscular,I
dystrophy,dystrophy,I
dystrophin,isoforms,O
isoforms,dystrophin,O
related,related,O
Are,Are,O
Dp140,Dp140,O
,,
concurrently,performed,O
in,order,O
neuropsychological,neuropsychological,O
cognitive,cognitive,B
(,(,O
explanation,explanation,O
DMD,DMD,B
Duchenne,Duchenne,B
muscular,muscular,I
DMD,DMD,B
molecular,a,O
observed,the,O
for,for,O
a,molecular,O
with,with,O
impairment,impairment,I
in,in,O
patients,patients,O
Molecular,Molecular,O
order,to,O
were,analysis,O
dystrophy,dystrophy,I
find,find,O
patients,patients,O
most,most,O
performed,concurrently,O
study,study,O
the,observed,O
),),O
on,on,O
to,in,O
49,49,O
analysis,were,O
and,and,O
.,.,O
,,
.,.,O
gene,gene,O
of,the,O
DMD,DMD,B
the,different,O
relation,relation,O
of,of,O
dystrophin,dystrophin,O
analysis,complete,O
Complete,Analysis,O
promoters,promoters,O
in,in,O
and,deletions,O
localization,the,O
different,the,O
was,was,O
define,define,O
duplications,duplications,O
deletions,and,O
performed,performed,O
the,of,O
to,to,O
the,localization,O
to,to,O
,,
Qualitative,Qualitative,O
analysis,analysis,O
the,specific,O
testing,testing,O
for,for,O
also,were,O
transcript,and,O
of,exon,O
.,.,O
carried,out,O
of,of,O
specific,the,O
and,Dp71,O
the,the,O
Dp140,Dp140,O
out,carried,O
were,also,O
exon,of,O
Dp71,transcript,O
first,first,O
,,
reading,reading,O
",",",",O
memory,verbal,O
and,and,O
",",",",O
analysis,neuropsychological,O
Neuropsychological,Assessed,O
verbal,intelligence,O
.,.,O
assessed,analysis,O
verbal,verbal,O
and,and,O
intelligence,memory,O
visuospatial,visuospatial,O
skills,skills,O
,,
findings,psychometric,O
that,deletions,O
cognitive,cognitive,B
molecular,of,O
that,that,O
of,molecular,O
of,of,O
.,.,O
with,associated,O
in,distal,O
be,be,O
part,part,O
seemed,gene,O
and,and,O
distal,the,O
psychometric,findings,O
the,the,O
duplications,duplications,O
deletions,that,O
preferentially,preferentially,O
impairment,impairment,I
were,were,O
demonstrated,demonstrated,O
Comparison,Comparison,O
and,and,O
to,to,O
localized,localized,O
the,in,O
associated,with,O
gene,seemed,O
,,
in,in,O
patients,patients,O
four,four,O
Two,Altered,O
sequences,DNA,O
Dp71,and,O
dysfunction,dysfunction,I
cerebral,cerebral,B
.,.,O
with,with,O
Dp140,Dp140,O
deleted,deleted,O
altered,two,O
transcripts,Dp71,O
and,transcripts,O
two,two,O
found,found,O
severe,severe,O
were,were,O
DNA,sequences,O
,,
distal,part,O
may,may,O
related,be,O
part,distal,O
suggest,that,O
and,and,O
.,.,O
isoforms,expressed,O
to,to,O
cognitive,cognitive,B
",",",",O
brain,brain,O
in,particular,O
some,some,O
impairment,impairment,I
",",",",O
with,with,O
sequences,sequences,O
the,the,O
.,.,O
associated,associated,O
DMD,DMD,B
some,some,O
in,in,O
the,the,O
DMD,DMD,B
in,the,O
gene,gene,O
be,related,O
particular,in,O
These,Findings,O
that,suggest,O
of,of,O
the,in,O
expressed,isoforms,O
located,located,O
the,the,O
findings,these,O
,,
polyposis,polyposis,I
family,family,O
hereditary,hereditary,B
non,a,O
and,and,O
in,mutations,O
-,-,I
APC,I1307K,O
with,with,O
colorectal,colorectal,I
Jewish,Jewish,O
hMLH1,in,O
mutations,hMLH1,O
I1307K,APC,O
cancer,cancer,I
non,non,I
.,.,O
-,-,O
a,non,O
,,
We,Describe,O
HNPCC,HNPCC,B
),),O
hereditary,hereditary,B
hMLH1,hMLH1,O
polyposis,polyposis,I
kindred,Canadian,O
mutation,truncating,O
truncating,mutation,O
a,a,O
-,-,I
describe,we,O
.,.,O
a,carries,O
French,kindred,O
cancer,cancer,I
(,(,O
colorectal,colorectal,I
carries,a,O
non,non,I
in,in,O
novel,novel,O
which,which,O
Canadian,French,O
,,
Interestingly,Interestingly,O
risk,risk,O
colorectal,colorectal,B
APC,polymorphism,O
",",",",O
of,is,O
cancer,cancer,I
the,I1307K,O
also,also,O
associated,with,O
polymorphism,APC,O
is,of,O
with,an,O
an,associated,O
",",",",O
",",",",O
increased,increased,O
in,present,O
.,.,O
I1307K,the,O
present,in,O
family,family,O
this,this,O
,,
of,of,O
has,previously,O
identified,identified,O
Ashkenazi,self,O
The,I1307K,O
been,been,O
previously,has,O
self,reported,O
reported,Ashkenazi,O
origins,Jewish,O
Jewish,origins,O
polymorphism,polymorphism,O
only,only,O
-,-,O
in,in,O
individuals,individuals,O
I1307K,the,O
.,.,O
,,
cancer,cancer,B
",",",",O
In,In,O
relationship,between,O
family,there,O
absence,or,O
there,family,O
between,relationship,O
.,.,O
",",",",O
be,be,O
presence,presence,O
I1307K,the,O
no,no,O
to,appears,O
polymorphism,polymorphism,O
or,absence,O
this,in,O
.,.,O
appears,to,O
of,of,O
the,and,O
addition,addition,O
and,the,O
the,I1307K,O
in,this,O
,,
the,the,O
a,Japanese,O
of,mutation,O
.,.,O
of,of,O
coproporphyria,coproporphyria,I
a,novel,O
mutation,of,O
CPO,gene,O
family,family,O
Japanese,a,O
gene,CPO,O
novel,a,O
in,in,O
hereditary,hereditary,B
Identification,Identification,O
,,
.,.,O
CPO,gene,O
an,characterized,O
CPO,a,O
in,in,O
disease,disease,I
autosomal,autosomal,B
of,of,I
dominant,dominant,I
oxidase,oxidase,I
coproporphyria,coproporphyria,I
by,a,O
coproporphyrinogen,coproporphyrinogen,I
deficiency,deficiency,B
the,the,O
gene,CPO,O
caused,caused,O
HCP,HCP,B
a,by,O
(,(,O
),),O
is,an,O
Hereditary,Hereditary,B
characterized,is,O
),),O
mutation,mutation,O
a,CPO,O
by,by,O
(,(,O
,,
in,reported,O
have,gene,O
HCP,HCP,B
mutations,11,O
of,of,O
reported,in,O
gene,have,O
11,only,O
the,the,O
Only,Mutations,O
been,been,O
patients,patients,O
.,.,O
,,
Japanese,family,O
mutation,another,O
report,report,O
another,mutation,O
in,in,O
family,a,O
a,Japanese,O
.,.,O
We,We,O
,,
T,T,O
C,C,O
demonstrated,analyses,O
sequence,and,O
substitution,substitution,O
to,to,O
for,for,O
chain,polymerase,O
",",",",O
analyses,demonstrated,O
polymorphism,polymorphism,O
Polymerase,Chain,O
conformational,strand,O
gene,gene,O
at,at,O
strand,conformational,O
a,a,O
mitochondria,mitochondria,O
the,in,O
in,in,O
the,the,O
targeting,to,O
lies,which,O
single,single,O
-,-,O
exon,exon,O
.,.,O
which,lies,O
position,85,O
reaction,reaction,O
direct,sequence,O
to,targeting,O
and,direct,O
1,1,O
presequence,putative,O
of,of,O
nucleotide,nucleotide,O
in,the,O
85,position,O
CPO,CPO,O
putative,presequence,O
,,
glutamine,glutamine,O
amino,at,O
codon,the,O
position,position,O
changes,changes,O
a,a,O
mutation,mutation,O
the,codon,O
at,amino,O
for,for,O
acid,acid,O
.,.,O
termination,codon,O
codon,termination,O
This,This,O
29,29,O
to,to,O
,,
two,showed,O
in,in,O
other,two,O
family,family,O
MaeI,MaeI,O
carriers,carriers,O
the,the,O
showed,analysis,O
restriction,restriction,O
analysis,other,O
.,.,O
,,
TIC,TIC,O
TIC,TIC,O
real,real,O
than,rather,O
alternative,alternative,O
TIC,1,O
is,the,O
located,within,O
),),O
-,-,O
within,located,O
putative,putative,O
the,is,O
supporting,supporting,O
",",",",O
.,.,O
that,that,O
-,-,O
.,.,O
is,is,O
The,The,O
T,C,O
rather,than,O
-,-,O
proposed,proposed,O
a,recently,O
1,1,O
initiation,codon,O
2,2,O
recently,a,O
(,(,O
1,TIC,O
TIC,TIC,O
C,T,O
-,-,O
translation,translation,O
mutation,mutation,O
codon,initiation,O
,,
associated,With,O
uremic,uremic,I
complement,complement,I
syndrome,syndrome,I
deficiency,deficiency,I
H,H,I
hemolytic,hemolytic,B
.,.,O
factor,factor,I
with,associated,O
Human,Human,B
,,
protein,protein,I
of,cases,O
regulatory,regulatory,I
This,Study,O
renal,renal,I
acute,acute,B
of,context,O
complement,complement,I
(,(,O
study,this,O
an,an,O
human,human,I
the,of,O
FH,FH,O
Factor,Factor,I
reports,reports,O
in,in,O
six,six,O
in,in,I
disease,disease,I
on,on,O
cases,of,O
H,H,I
),),O
context,the,O
.,.,O
deficiency,deficiency,B
the,the,I
,,
Five,Of,O
were,were,O
(,(,O
hemolytic,hemolytic,B
),),O
presenting,presenting,O
of,five,O
cases,cases,O
the,the,O
in,in,O
.,.,O
children,with,O
HUS,HUS,B
with,children,O
uremic,uremic,I
idiopathic,idiopathic,O
syndrome,syndrome,I
observed,observed,O
,,
Two,Two,O
),),O
-,-,O
of,of,O
by,by,O
bands,FHR,O
the,the,O
the,kD,O
(,(,O
1,like,O
and,and,O
-,-,O
),),O
deficiency,characterized,O
of,of,O
related,related,O
form,form,O
a,homozygous,O
-,-,O
of,of,O
",",",",O
",",",",O
-,-,O
immunoblotting,immunoblotting,O
other,other,O
protein,protein,O
kD,kD,O
150,the,O
.,.,O
protein,1,O
absence,absence,O
FHL,FHL,O
like,protein,O
of,of,O
the,the,O
kD,150,O
exhibited,exhibited,O
children,children,O
-,-,O
FHR,bands,O
FH,FH,O
Factor,Factor,O
and,and,O
Factor,Factor,O
homozygous,a,O
the,the,O
presence,upon,O
H,H,O
the,the,O
H,H,O
1,1,O
upon,presence,O
(,(,O
42,42,O
characterized,deficiency,O
,,
large,large,O
the,FH,O
the,underlying,O
homozygous,deficiency,O
the,deficiency,O
with,with,O
the,out,O
gene,as,O
of,presence,O
defect,defect,O
as,gene,O
a,a,O
analysis,of,O
one,one,O
and,and,O
deletion,deletion,O
for,for,O
deficiency,homozygous,O
ruled,ruled,O
.,.,O
DNA,of,O
PCR,PCR,O
patient,patient,O
Southern,Blot,O
of,DNA,O
of,analysis,O
deficiency,the,O
of,of,O
blot,southern,O
FH,the,O
presence,of,O
underlying,the,O
out,the,O
,,
other,other,O
the,of,O
presented,presented,O
of,FH,O
family,the,O
pattern,pattern,O
The,The,O
and,deficiency,O
heterozygous,heterozygous,O
FH,family,O
of,proteins,O
children,children,O
a,exhibited,O
with,with,O
four,four,O
immunoblotting,immunoblotting,O
deficiency,and,O
normal,normal,O
exhibited,a,O
proteins,of,O
.,.,O
,,
is,the,O
associated,only,O
Factor,Factor,B
deficiency,deficiency,I
deficiency,deficiency,I
.,.,O
the,is,O
complement,complement,B
HUS,HUS,B
with,with,O
only,associated,O
H,H,I
,,
These,These,O
for,for,O
the,in,O
role,suggest,O
a,role,O
/,/,O
observations,observations,O
FH,FH,O
and,and,O
pathogenesis,the,O
FH,FH,O
HUS,HUS,B
suggest,a,O
or,or,O
.,.,O
idiopathic,of,O
of,idiopathic,O
.,.,O
in,pathogenesis,O
receptors,receptors,O
,,
ancient,ancient,O
the,in,O
population,population,O
Further,Further,O
a,major,O
Japanese,Japanese,O
in,the,O
studies,studies,O
myotonic,myotonic,B
evidence,evidence,O
disequilibrium,disequilibrium,O
.,.,O
from,from,O
for,a,O
underlying,underlying,O
linkage,linkage,O
major,for,O
dystrophy,dystrophy,I
mutation,mutation,O
,,
repeat,n,O
50,to,O
copy,a,O
normal,normal,O
(,(,O
DM,DM,B
),),O
5,of,O
but,chromosomes,O
to,50,O
an,an,O
of,5,O
unstable,unstable,O
n,repeat,O
chromosomes,but,O
mutation,mutation,O
copies,copies,O
.,.,O
),),O
is,is,O
repeats,37,O
",",",",O
3000,3000,O
myotonic,myotonic,B
at,at,O
The,The,O
DM,DM,B
dystrophy,dystrophy,I
-,-,O
present,present,O
CTG,CTG,O
(,(,O
amplified,amplified,O
chromosomes,chromosomes,O
on,on,O
on,on,O
number,copy,O
-,-,O
a,number,O
37,repeats,O
,,
molecular,the,O
populations,Caucasian,O
question,question,O
events,events,O
a,a,O
the,molecular,O
of,of,O
findings,findings,O
DM,DM,B
in,in,O
raise,chromosome,O
expansion,mutation,O
founder,a,O
involved,in,O
.,.,O
Previous,Previous,O
in,involved,O
about,about,O
a,founder,O
mutation,the,O
the,expansion,O
chromosome,raise,O
Caucasian,populations,O
,,
),),O
haplotypes,haplotypes,O
the,CTG,O
near,markers,O
region,region,O
we,we,O
mutation,mutation,O
for,the,O
(,(,O
repeat,n,O
a,founder,O
and,and,O
in,exists,O
",",",",O
n,repeat,O
the,for,O
exists,in,O
investigate,to,O
markers,near,O
constructed,constructed,O
polymorphic,polymorphic,O
whether,whether,O
.,.,O
chromosome,chromosome,O
DM,DM,B
genotyped,genotyped,O
founder,a,O
To,Investigate,O
population,population,O
Japanese,the,O
families,using,O
the,Japanese,O
using,families,O
CTG,the,O
,,
were,were,O
haplotype,haplotype,O
Six,Six,O
always,always,O
found,found,O
haplotypes,haplotypes,O
alleles,alleles,O
and,and,O
.,.,O
A,A,O
were,were,O
different,different,O
DM,DM,B
,,
.,.,O
comprising,families,O
130,130,O
origin,origin,O
Japanese,90,O
members,unaffected,O
Japanese,population,O
the,the,O
and,to,O
affected,affected,O
mechanism,mechanism,O
investigate,the,O
unaffected,members,O
an,an,O
the,the,O
CTG,CTG,O
mutation,mutation,O
we,have,O
of,of,O
have,we,O
of,of,O
find,find,O
studied,studied,O
90,Japanese,O
190,190,O
DM,DM,B
in,expansion,O
to,and,O
mutation,in,O
and,and,O
To,To,O
the,the,O
expansion,mutation,O
),),O
families,comprising,O
population,Japanese,O
n,repeat,O
(,(,O
the,investigate,O
repeat,n,O
,,
19,19,O
expansion,expansion,O
ancestral,mutations,O
mutations,ancestral,O
both,Caucasian,O
suggest,suggest,O
an,an,O
populations,Japanese,O
have,have,O
to,n,O
The,Results,O
by,by,O
results,the,O
n,to,O
Japanese,populations,O
=,=,O
ancestral,ancestral,O
common,common,O
and,and,O
a,a,O
Caucasian,both,O
repeat,5,O
n,n,O
originated,originated,O
37,copies,O
copies,37,O
=,=,O
in,in,O
5,repeat,O
that,that,O
-,-,O
.,.,O
of,of,O
few,few,O
,,
triplet,triplet,O
that,that,O
repeat,repeat,O
data,support,O
for,both,O
These,Data,O
.,.,O
ataxia,ataxia,I
have,have,O
and,for,O
Friedreichs,Friedreichs,B
DM,DM,B
models,multistep,O
proposed,proposed,O
expansion,expansion,O
.,.,O
support,these,O
both,and,O
of,of,O
been,been,O
multistep,models,O
,,
.,.,O
Africa,Africa,O
The,The,O
the,the,O
C6,C6,B
",",",",O
western,Cape,O
in,in,O
basis,molecular,O
of,of,O
molecular,basis,O
Cape,South,O
South,western,O
deficiency,deficiency,I
,,
Deficiency,Deficiency,B
human,human,I
of,of,O
.,.,O
",",",",O
complement,complement,I
sixth,sixth,I
number,number,O
),),O
component,component,I
in,a,O
has,has,O
the,the,I
reported,reported,O
the,from,O
Africa,Africa,O
Cape,Cape,O
been,been,O
of,of,I
(,(,O
of,of,I
C6,C6,O
from,families,O
western,western,O
a,in,O
families,the,O
South,South,O
,,
been,ascertained,O
.,.,O
endemic,is,O
of,of,O
and,Cape,O
disease,recurrent,O
all,all,O
disease,disease,I
C6Q0,C6Q0,O
(,(,O
Meningococcal,Meningococcal,B
because,been,O
recurrent,disease,O
almost,almost,O
ascertained,because,O
),),O
the,in,O
of,of,O
pedigrees,pedigrees,O
total,total,O
Cape,and,O
C6,C6,B
is,endemic,O
deficiency,deficiency,I
in,the,O
have,have,O
,,
hitherto,and,O
gene,gene,O
and,and,O
have,have,O
1936delG,1936delG,O
in,in,O
three,three,O
the,is,O
the,the,O
Cape,the,O
sequenced,sequenced,O
to,to,O
.,.,O
and,unreported,O
unreported,hitherto,O
leading,defects,O
total,total,O
deficiency,deficiency,O
is,the,O
expressed,expressed,O
Americans,African,O
which,which,O
and,1195delC,O
which,which,O
common,common,O
found,found,O
reported,reported,O
defects,leading,O
C6,C6,O
defect,defect,O
the,the,O
from,from,O
-,-,O
1195delC,and,O
and,and,O
",",",",O
have,have,O
exons,exons,O
We,We,O
molecular,molecular,O
selected,cases,O
have,have,O
the,Cape,O
879delG,879delG,O
cases,selected,O
in,in,O
",",",",O
previously,previously,O
of,of,O
been,been,O
African,Americans,O
",",",",O
,,
defects,defects,O
are,are,O
",",",",O
1195delC,1195delC,O
/,/,O
that,show,O
the,the,O
region,C7,O
also,we,O
C6,C6,O
DNA,DNA,O
marker,haplotypes,O
associated,associated,O
characteristic,characteristic,O
show,that,O
small,although,O
although,small,O
observed,observed,O
879delG,879delG,O
were,variations,O
and,and,O
with,with,O
haplotypes,marker,O
We,Also,O
C7,region,O
.,.,O
variations,were,O
,,
defect,1936delG,O
was,defect,O
be,could,O
observed,only,O
its,its,O
.,.,O
once,in,O
could,be,O
deduced,deduced,O
1936delG,was,O
but,Cape,O
associated,associated,O
The,The,O
the,the,O
Cape,but,O
",",",",O
haplotype,haplotype,O
in,once,O
only,observed,O
,,
unrelated,unrelated,O
.,.,O
data,the,O
in,all,O
studied,studied,O
38,C6Q0,O
defects,the,O
haplotypes,indicate,O
from,from,O
from,from,O
The,Data,O
account,for,O
we,we,O
defects,defects,O
C6Q0,38,O
that,these,O
have,have,O
for,account,O
Cape,Cape,O
individuals,individuals,O
molecular,molecular,O
the,the,O
the,the,O
all,in,O
three,three,O
indicate,haplotypes,O
these,that,O
the,defects,O
the,the,O
,,
but,but,O
the,the,O
the,observed,O
defect,in,O
-,-,I
in,defect,O
also,have,O
come,not,O
879delG,the,O
observed,879delG,O
defect,defect,O
Cape,probably,O
not,come,O
two,in,O
did,did,O
from,from,O
Dutch,Dutch,O
.,.,O
",",",",O
We,We,O
C6,C6,B
probably,Cape,O
.,.,O
kindreds,kindreds,O
in,two,O
The,The,O
879delG,the,O
deficient,deficient,I
have,also,O
Netherlands,Netherlands,O
the,879delG,O
,,
:,:,O
further,further,O
C7,C7,I
seven,seven,O
molecular,molecular,O
.,.,O
associated,marker,O
defects,and,O
haplotypes,associated,O
marker,haplotypes,O
Complement,Complement,B
and,defects,O
their,their,O
deficiency,deficiency,I
,,
C7,C7,B
described,described,O
Seven,Further,O
bases,are,O
further,seven,O
.,.,O
molecular,molecular,O
are,of,O
of,bases,O
deficiency,deficiency,I
,,
codons,codons,O
deletions,and,O
new,these,O
defects,single,O
",",",",O
-,-,O
",",",",O
and,deletions,O
of,of,O
involve,molecular,O
single,involve,O
some,some,O
molecular,defects,O
All,All,O
these,new,O
",",",",O
others,others,O
sites,sites,O
.,.,O
and,and,O
nucleotide,nucleotide,O
which,splice,O
alter,which,O
splice,alter,O
substitutions,substitutions,O
events,events,O
,,
end,end,O
but,but,O
",",",",O
.,.,O
the,the,O
gene,gene,O
towards,towards,O
predominantly,predominantly,O
are,they,O
along,along,O
C7,the,O
distributed,distributed,O
3,3,O
They,Are,O
the,C7,O
,,
in,in,O
All,All,O
individuals,heterozygous,O
.,.,O
found,were,O
heterozygous,compound,O
compound,individuals,O
were,found,O
,,
are,are,O
.,.,O
with,most,O
.,.,O
marker,marker,O
C7,C7,O
haplotypes,associated,O
tabulated,tabulated,O
C7,C7,B
C6,the,O
most,with,O
defects,defects,I
The,C6,O
/,/,O
associated,haplotypes,O
,,
linked,to,O
wellness,wellness,O
chromosomal,for,O
A,Genome,O
the,the,O
affective,affective,I
wide,search,O
disorder,disorder,I
loci,loci,O
risk,for,O
health,health,O
Amish,Amish,O
among,among,O
genome,a,O
for,risk,O
bipolar,bipolar,B
search,wide,O
.,.,O
Order,Order,O
-,-,O
relatives,relatives,O
in,in,O
mental,mental,O
to,linked,O
for,chromosomal,O
at,at,O
high,high,O
Old,Old,O
,,
BPAD,BPAD,B
of,of,O
or,and,O
with,periods,O
is,Characterized,O
disorder,disorder,I
),),O
by,by,O
depression,depression,B
Bipolar,Bipolar,B
hypomania,hypomania,B
depressive,depressive,I
;,;,O
illness,illness,I
.,.,O
episodes,episodes,O
interspersed,interspersed,O
characterized,is,O
/,/,O
affective,affective,I
of,with,O
-,-,I
and,or,O
periods,of,O
mania,mania,B
manic,manic,B
(,(,O
,,
genetic,genetic,O
susceptibility,susceptibility,O
to,to,O
develop,develop,O
.,.,O
a,supports,O
the,in,O
supports,a,O
Compelling,Compelling,O
evidence,evidence,O
in,the,O
component,component,O
BPAD,BPAD,B
significant,significant,O
,,
or,or,O
however,however,O
have,attempted,O
chromosomal,loci,O
that,chromosomal,O
date,to,O
cause,cause,O
identify,identify,O
risk,the,O
the,risk,O
of,developing,O
to,to,O
",",",",O
BPAD,BPAD,B
attempted,have,O
loci,that,O
only,only,O
To,Date,O
.,.,O
studies,studies,O
linkage,linkage,O
developing,of,O
increase,increase,O
",",",",O
,,
similar,developing,O
whether,determine,O
Amish,Amish,O
of,of,O
of,of,O
),),O
there,there,O
protective,protective,O
mental,mental,O
wide,wide,O
to,to,O
our,our,O
Old,multigeneration,O
extremely,extremely,O
To,Whether,O
BPAD,BPAD,B
determine,to,O
in,in,O
other,other,O
multigeneration,Old,O
",",",",O
be,be,O
the,the,O
developing,similar,O
linkage,linkage,O
several,several,O
the,reduce,O
",",",",O
risk,risk,O
alleles,alleles,O
an,an,O
in,in,O
is,is,O
we,used,O
-,-,O
pedigrees,pedigrees,O
incidence,high,O
observed,observed,O
prevent,prevent,O
BPAD,BPAD,B
psychiatric,psychiatric,B
(,(,O
of,of,O
any,any,O
large,large,O
as,as,O
wellness,wellness,O
disorder,disorder,I
Order,Order,O
of,absence,O
high,incidence,O
genetic,genetic,B
that,that,O
.,.,O
reduce,the,O
health,health,O
used,we,O
disorders,disorders,I
what,what,O
genome,genome,O
exhibiting,exhibiting,O
could,could,O
or,or,O
scan,scan,O
phenotype,phenotype,O
absence,of,O
,,
=,=,O
(,(,O
at,at,O
2,2,O
locus,a,O
a,locus,O
4,4,O
4q,4q,O
nonparametric,linkage,O
;,;,O
on,on,O
Pempirical,Pempirical,O
evidence,evidence,O
<,<,O
22,22,O
x,x,O
for,for,O
(,(,O
x,x,O
05,05,O
D4S2949,D4S2949,O
have,have,O
57,57,O
a,locus,O
score,score,O
.,.,O
(,(,O
3,10,O
29,P,O
P,P,O
nonparametric,nonparametric,O
-,-,O
.,.,O
),),O
(,(,O
-,-,O
=,=,O
(,(,O
-,-,O
linkage,linkage,O
PLUS,PLUS,O
P,29,O
on,on,O
suggestive,suggestive,O
chromosome,chromosome,O
strong,strong,O
value,value,O
found,found,O
10,10,O
score,score,O
linkage,nonparametric,O
4p,4p,O
maximum,maximum,O
and,and,O
GENEHUNTER,GENEHUNTER,O
=,=,O
",",",",O
maximum,maximum,O
chromosome,chromosome,O
.,.,O
3,3,O
D4S397,D4S397,O
PLUS,PLUS,O
for,for,O
),),O
5,5,O
-,-,O
3,10,O
.,.,O
4,SIBPAL,O
locus,a,O
),),O
at,at,O
5,5,O
10,3,O
evidence,evidence,O
SIBPAL,4,O
x,3,O
10,x,O
",",",",O
We,We,O
-,-,O
GENEHUNTER,GENEHUNTER,O
=,=,O
,,
SIBPAL,SIBPAL,O
x,1,O
(,(,O
health,mental,O
linked,linked,O
are,are,O
),),O
mental,health,O
1,value,O
.,.,O
3,3,O
Pempirical,Pempirical,O
to,to,O
that,that,O
),),O
wellness,wellness,O
-,-,O
;,;,O
value,x,O
10,10,O
<,<,O
),),O
,,
consistent,consistent,O
clinical,clinical,O
findings,are,O
alleles,alleles,O
prevent,prevent,O
hypothesis,hypothesis,O
or,or,O
related,other,O
and,manifestations,O
manifestations,of,O
certain,certain,O
the,the,O
could,could,O
other,related,O
disorders,disorders,I
with,with,O
affective,affective,B
the,modify,O
.,.,O
that,that,O
These,These,O
are,findings,O
perhaps,perhaps,O
of,and,O
BPAD,BPAD,B
modify,the,O
,,
.,.,O
distortion,segregation,O
in,in,O
Segregation,Distortion,O
myotonic,myotonic,B
dystrophy,dystrophy,I
,,
),),O
DM,DM,B
three,generation,O
dominant,dominant,I
is,is,O
shows,pedigree,O
a,a,O
which,an,O
generation,three,O
anticipation,cascade,O
(,(,O
in,in,O
dystrophy,dystrophy,I
an,which,O
the,the,O
.,.,O
autosomal,autosomal,B
typical,typical,O
",",",",O
pedigree,shows,O
",",",",O
Myotonic,Myotonic,B
disease,disease,I
cascade,anticipation,O
,,
results,this,O
in,that,O
with,the,O
(,(,O
infertility,infertility,B
of,of,O
dystrophy,dystrophy,I
the,with,O
disappearance,disappearance,O
myotonic,myotonic,I
DM,DM,B
),),O
pedigree,pedigree,O
CDM,CDM,B
.,.,O
This,Results,O
that,in,O
in,and,O
congenital,congenital,B
and,in,O
,,
distortion,segregation,O
the,locus,O
transmission,is,O
DM,DM,B
concept,concept,O
DM,DM,B
where,where,O
population,the,O
in,in,O
of,of,O
",",",",O
to,explain,O
larger,the,O
the,larger,O
",",",",O
of,of,O
the,population,O
put,been,O
The,The,O
forward,forward,O
there,there,O
at,at,O
.,.,O
explain,to,O
has,has,O
the,the,O
locus,the,O
preferential,transmission,O
maintenance,of,O
been,put,O
partially,partially,O
is,preferential,O
segregation,distortion,O
of,maintenance,O
allele,allele,O
,,
were,59,O
survey,of,O
pedigrees,were,O
a,a,O
",",",",O
.,.,O
in,in,O
DM,DM,B
Ireland,Northern,O
59,pedigrees,O
In,In,O
ascertained,ascertained,O
Northern,Ireland,O
of,survey,O
,,
been,had,O
where,status,O
their,their,O
to,to,O
had,were,O
the,the,O
to,to,O
identified,been,O
of,of,O
determine,determine,O
the,the,O
offspring,offspring,O
examined,examined,O
status,the,O
the,where,O
DM,DM,B
transmission,transmission,O
Sibships,Sibships,O
from,from,O
of,of,O
parents,affected,O
affected,parents,O
all,all,O
were,identified,O
the,the,O
expansion,expansion,O
members,members,O
.,.,O
,,
",",",",O
male,58,O
58,male,O
transmitting,where,O
.,.,O
the,transmitting,O
parent,parent,O
was,was,O
Where,The,O
,,
3,3,O
.,.,O
affected,were,O
a,female,O
female,of,O
",",",",O
68,68,O
offspring,affected,O
were,offspring,O
case,the,O
",",",",O
of,a,O
in,in,O
%,%,O
the,the,O
transmitting,transmitting,O
the,case,O
and,and,O
of,of,O
parent,parent,O
,,
%,%,O
affected,were,O
.,.,O
were,affected,O
7,7,O
,,
at,at,O
allele,the,O
the,the,O
.,.,O
meiotic,meiotic,O
in,in,O
shown,have,O
non,DM,O
larger,allele,O
locus,locus,O
-,-,O
on,studies,O
DM,DM,B
CTGn,for,O
for,CTGn,O
Studies,On,O
the,of,O
DM,non,O
in,in,O
increased,increased,O
heterozygotes,heterozygotes,O
of,larger,O
have,shown,O
drive,drive,O
DM,DM,B
transmission,transmission,O
,,
to,be,O
evidence,that,O
provides,provides,O
transmitted,preferentially,O
expansion,the,O
tends,tends,O
DM,DM,B
study,study,O
.,.,O
preferentially,transmitted,O
the,expansion,O
that,evidence,O
be,to,O
further,further,O
This,This,O
,,
.,.,O
of,diagnosis,O
Diagnosis,Of,O
hemochromatosis,hemochromatosis,B
,,
death,death,I
disease,the,O
under,under,O
untreated,untreated,O
.,.,O
can,can,O
but,disease,O
and,and,O
serious,illness,O
",",",",O
illness,serious,O
hemochromatosis,hemochromatosis,B
If,If,O
",",",",O
cause,cause,O
diagnosed,diagnosed,O
-,-,O
is,is,O
the,but,O
substantially,substantially,O
early,early,B
still,still,O
,,
level,level,O
transferrin,transferrin,O
serum,serum,O
and,case,O
cornerstone,screening,O
.,.,O
detection,detection,O
ferritin,ferritin,O
serum,the,O
of,the,O
and,saturation,O
is,is,O
saturation,and,O
the,the,O
the,serum,O
measurement,measurement,O
screening,of,O
The,Cornerstone,O
of,of,O
case,and,O
,,
liver,liver,O
physicians,physicians,O
",",",",O
overload,overload,I
levels,levels,O
to,to,O
biopsy,biopsy,O
must,use,O
.,.,O
is,suspected,O
specimens,specimens,O
the,the,O
Once,Once,O
of,presence,O
ferritin,ferritin,O
iron,iron,O
use,must,O
serum,serum,O
the,the,O
and,and,O
on,stores,O
stores,on,O
suspected,is,O
for,for,O
hepatic,hepatic,O
iron,iron,B
patients,patients,O
diagnosis,diagnosis,O
assess,assess,O
presence,of,O
,,
Liver,Liver,O
of,of,O
is,biopsy,O
absence,absence,O
",",",",O
can,which,O
affect,affect,O
and,and,O
used,used,O
presence,or,O
to,to,O
or,presence,O
.,.,O
management,management,O
cirrhosis,cirrhosis,B
which,can,O
biopsy,is,O
also,also,O
prognosis,prognosis,O
the,establish,O
establish,the,O
,,
being,being,O
-,-,O
still,still,O
test,test,O
place,its,O
the,the,O
based,based,O
DNA,DNA,O
the,for,O
evaluated,evaluated,O
is,is,O
A,A,O
in,in,O
but,but,O
gene,HFE,O
available,available,O
for,the,O
hemochromatosis,hemochromatosis,B
is,is,O
commercially,commercially,O
of,of,O
diagnosis,diagnosis,O
",",",",O
.,.,O
HFE,gene,O
its,place,O
,,
disease,disease,O
for,role,O
useful,the,O
is,is,O
family,family,O
the,most,O
hemochromatosis,hemochromatosis,B
this,test,O
the,of,O
in,the,O
of,case,O
with,a,O
role,for,O
of,in,O
test,this,O
proven,proven,O
case,of,O
",",",",O
the,the,O
the,the,O
a,with,O
detection,detection,O
most,useful,O
Currently,Currently,O
members,members,O
patients,patients,O
of,of,O
.,.,O
in,in,O
,,
even,can,O
hemochromatosis,hemochromatosis,B
and,and,O
therapy,can,O
crucial,crucial,O
.,.,O
It,It,O
hepatic,hepatic,B
cirrhosis,cirrhosis,I
develops,before,O
can,phlebotomy,O
can,even,O
diagnose,diagnose,O
to,to,O
disease,disease,O
life,life,O
expectancy,expectancy,O
to,to,O
avert,chronic,O
phlebotomy,therapy,O
is,is,O
.,.,O
chronic,avert,O
normal,normal,O
serious,serious,O
because,because,O
lead,lead,O
before,develops,O
,,
in,variant,O
APC,APC,B
for,for,O
cancer,cancer,I
and,origin,O
risk,risk,O
.,.,O
the,I1307K,O
gene,the,O
differing,of,O
origin,and,O
Israeli,Israeli,O
variant,in,O
colorectal,colorectal,B
Prevalence,Prevalence,O
Jews,Jews,O
of,differing,O
ethnic,ethnic,O
of,of,O
I1307K,gene,O
,,
the,highest,O
European,European,O
.,.,O
group,ethnic,O
.,.,O
of,of,O
Israeli,Jews,O
colorectal,colorectal,B
e,e,O
i,i,O
&,&,O
",",",",O
have,Ashkenazim,O
",",",",O
Jews,Israeli,O
Ashkenazim,have,O
",",",",O
cancer,cancer,I
AIMS,AIMS,O
.,.,O
BACKGROUND,BACKGROUND,O
Israeli,Israeli,O
birth,birth,O
highest,the,O
incidence,incidence,O
ethnic,group,O
of,of,O
any,any,O
,,
I1307K,the,O
6,in,O
APC,APC,B
The,I1307K,O
variant,was,O
found,found,O
gene,gene,O
was,variant,O
in,6,O
.,.,O
,,
but,cases,O
colorectal,colorectal,B
of,28,O
",",",",O
28,of,O
1,of,O
%,%,O
%,%,O
",",",",O
familial,their,O
cancer,cancer,I
Jews,Jews,O
non,non,O
cases,but,O
their,familial,O
-,-,O
American,Jews,O
of,1,O
in,in,O
.,.,O
not,not,O
Jews,American,O
,,
colorectal,colorectal,B
assessed,the,O
risk,risk,O
the,assessed,O
.,.,O
origin,and,O
prevalence,prevalence,O
ethnic,ethnic,O
Israeli,in,O
and,origin,O
cancer,cancer,I
for,for,O
I1307K,I1307K,O
in,Jews,O
of,differing,O
differing,of,O
We,We,O
Jews,Israeli,O
,,
method,method,O
by,by,O
European,European,O
samples,from,O
I1307K,I1307K,O
the,the,O
family,or,O
for,for,O
),),O
origin,with,O
oligonucleotide,specific,O
of,of,O
without,a,O
",",",",O
ASO,ASO,O
.,.,O
history,history,O
examined,were,O
/,/,O
(,(,O
-,-,O
variant,variant,O
European,non,O
or,family,O
a,without,O
",",",",O
500,500,O
METHODS,METHODS,O
non,or,O
with,origin,O
or,or,O
personal,personal,O
neoplasia,neoplasia,B
of,unrelated,O
and,and,O
allele,allele,O
specific,oligonucleotide,O
unrelated,Jews,O
Jews,of,O
DNA,DNA,O
the,the,O
from,samples,O
-,-,O
or,European,O
were,examined,O
,,
persons,In,O
.,.,O
I1307K,for,O
risk,risk,O
at,persons,O
for,I1307K,O
",",",",O
cancer,cancer,I
found,in,O
colorectal,colorectal,B
In,at,O
5,5,O
in,found,O
RESULTS,RESULTS,O
was,was,O
average,average,O
,,
1,1,O
European,and,O
.,.,O
0,Of,O
120,120,O
%,%,O
of,0,O
and,European,O
,,
%,%,O
0,0,O
-,-,O
08,08,O
of,6,O
P,Jews,O
6,Of,O
=,=,O
.,.,O
(,(,O
),),O
Jews,P,O
non,188,O
.,.,O
European,European,O
188,non,O
,,
15,15,O
It,Occurred,O
.,.,O
in,it,O
occurred,in,O
,,
4,4,O
cancer,cancer,B
0,02,O
of,of,O
52,52,O
=,=,O
Ashkenazi,Ashkenazi,O
at,Jews,O
.,.,O
and,and,O
risk,risk,O
familial,with,O
02,0,O
.,.,O
increased,increased,O
%,%,O
in,detected,O
not,not,O
51,51,O
Jews,European,O
Israelis,Israelis,O
-,-,O
(,(,O
with,familial,O
non,non,O
P,P,O
was,was,O
cancer,cancer,B
),),O
detected,in,O
European,at,O
,,
neoplasia,neoplasia,I
families,families,O
occurred,occurred,O
noncolonic,of,O
",",",",O
I1307K,carriers,O
or,family,O
in,or,O
Ashkenazi,Ashkenazi,O
personal,or,O
20,20,O
carriers,I1307K,O
had,of,O
history,history,O
.,.,O
of,of,O
8,8,O
the,the,O
of,of,O
also,had,O
of,whom,O
13,13,O
Colorectal,Colorectal,B
personally,personally,O
or,in,O
whom,also,O
neoplasia,neoplasia,B
family,personal,O
of,noncolonic,O
a,a,O
,,
cancer,cancer,I
The,CONCLUSIONS,O
I1307K,The,O
and,and,O
or,or,I
Ashkenazi,in,O
Jews,Jews,O
may,may,O
in,Ashkenazi,O
the,the,O
of,incidence,O
European,in,O
cancers,cancers,I
for,for,O
other,other,I
susceptibility,susceptibility,O
incidence,European,O
variant,variant,O
higher,higher,O
.,.,O
explains,partially,O
in,of,O
Israelis,Israelis,O
a,represent,O
represent,a,O
",",",",O
CONCLUSIONS,I1307K,O
",",",",I
colorectal,colorectal,B
partially,explains,O
",",",",I
APC,APC,O
colorectal,colorectal,B
gene,gene,O
,,
.,.,O
hereditary,hereditary,B
gene,gene,O
of,analysis,O
coproporphyria,coproporphyria,I
coproporphyrinogen,oxidase,O
in,in,O
Systematic,Of,O
defects,defects,O
mutation,update,O
oxidase,coproporphyrinogen,O
and,and,O
update,mutation,O
analysis,systematic,O
,,
coproporphyria,coproporphyria,I
is,is,O
coproporphyrinogen,coproporphyrinogen,I
acute,autosomal,O
),),O
activity,activity,I
caused,by,O
),),O
an,an,O
dominant,dominant,O
by,caused,O
inheritance,inheritance,O
deficient,deficient,B
with,acute,O
(,(,O
CPO,CPO,O
Hereditary,Hereditary,B
III,III,I
oxidase,oxidase,I
autosomal,with,O
(,(,O
HC,HC,B
hepatic,hepatic,B
of,of,I
.,.,O
porphyria,porphyria,I
,,
precipitated,precipitated,O
Clinical,Manifestations,O
diseases,diseases,I
",",",",O
the,of,O
manifestations,clinical,O
",",",",O
or,changes,O
characterized,by,O
often,often,O
infectious,infectious,B
.,.,O
hormonal,hormonal,O
changes,or,O
dysfunction,dysfunction,I
fasting,cyclical,O
acute,acute,O
cyclical,fasting,O
attacks,attacks,O
neurological,neurological,B
by,characterized,O
drugs,drugs,O
by,by,O
are,disease,O
disease,are,O
",",",",O
of,the,O
of,of,O
,,
also,also,O
photosensitivity,may,O
Skin,Skin,O
may,photosensitivity,O
.,.,O
present,be,O
be,present,O
,,
exon,by,O
from,from,O
followed,DGGE,O
part,part,O
Czech,and,O
exon,exon,O
gradient,denaturing,O
by,by,O
3,3,O
an,by,O
",",",",O
heterozygous,heterozygous,O
electrophoresis,electrophoresis,O
gene,gene,O
-,-,O
CPO,CPO,O
strategy,followed,O
seven,the,O
Holland,Holland,O
the,the,O
France,France,O
sequencing,in,O
unrelated,unrelated,O
sequence,sequence,O
",",",",O
patients,patients,O
-,-,O
by,exon,O
boundaries,boundaries,O
noncoding,noncoding,O
denaturing,gradient,O
The,Seven,O
direct,direct,O
systematically,systematically,O
of,of,O
the,exons,O
exon,exon,O
exons,the,O
gel,gel,O
),),O
intron,intron,O
and,Czech,O
",",",",O
DGGE,strategy,O
of,of,O
(,(,O
analyzed,analyzed,O
and,and,O
by,an,O
HC,HC,B
were,were,O
/,/,O
in,sequencing,O
seven,seven,O
.,.,O
Republic,Republic,O
,,
mutations,and,O
new,new,O
two,two,O
were,detected,O
Seven,Seven,O
.,.,O
and,mutations,O
novel,novel,O
polymorphisms,were,O
detected,polymorphisms,O
,,
(,(,O
site,site,O
a,a,O
are,two,O
g,15c,O
.,.,O
a,a,O
",",",",O
nonsense,nonsense,O
is,is,O
mutations,mutations,O
mutation,mutation,O
two,two,O
new,new,O
W427R,W427R,O
missense,missense,O
(,(,O
a,a,O
Among,These,O
-,-,O
which,which,O
acceptor,acceptor,O
662de14bp,1168del3bp,O
),),O
and,and,O
two,are,O
>,>,O
;,;,O
position,position,O
",",",",O
splicing,splicing,O
splice,splice,O
Q385X,Q306X,O
Q306X,Q385X,O
at,at,O
),),O
small,small,O
glycine,glycine,O
-,-,O
1168del3bp,662de14bp,O
IVS1,g,O
",",",",O
",",",",O
15c,IVS1,O
(,(,O
two,two,O
),),O
(,(,O
these,among,O
-,-,O
creates,creates,O
",",",",O
390,390,O
),),O
deletions,deletions,O
G197W,G197W,O
one,one,O
are,are,O
removing,removing,O
are,are,O
,,
site,site,O
-,-,O
respective,respective,O
390delGly,390delGly,O
system,using,O
expression,expression,O
of,the,O
mutations,G197W,O
point,point,O
-,-,O
in,in,O
.,.,O
the,of,O
",",",",O
the,and,O
",",",",O
deletion,deletion,O
W427R,W427R,O
The,Pathological,O
G197W,mutations,O
pathological,the,O
by,by,O
significance,significance,O
using,system,O
frame,in,O
assessed,assessed,O
and,the,O
their,their,O
in,frame,O
prokaryotic,prokaryotic,O
were,were,O
directed,mutagenesis,O
mutagenesis,directed,O
a,a,O
,,
in,resulted,O
the,the,O
a,or,O
of,of,O
absence,absence,O
.,.,O
activity,activity,O
dramatic,dramatic,O
CPO,CPO,O
mutations,mutations,O
resulted,in,O
These,These,O
or,a,O
decrease,decrease,O
,,
+,+,O
polymorphisms,polymorphisms,O
2,and,O
574,bp,O
bp,bp,O
two,two,O
from,the,O
a,6,O
noncoding,noncoding,O
(,(,O
1,1,O
C,G,O
),),O
localized,in,O
base,base,O
G,C,O
deletion,deletion,O
the,in,O
G,G,O
a,a,O
downstream,downstream,O
noncoding,noncoding,O
/,/,O
.,.,O
region,region,O
),),O
the,the,O
transcriptional,initiation,O
part,of,O
574,574,O
the,the,O
-,-,O
of,of,O
of,of,O
of,part,O
last,last,O
the,the,O
/,/,O
6,a,O
),),O
),),O
the,the,O
bp,bp,O
bp,574,O
in,localized,O
polymorphism,in,O
of,of,O
polymorphism,polymorphism,O
142C,142C,O
normal,normal,O
(,(,O
codon,codon,O
",",",",O
",",",",O
initiation,transcriptional,O
delATTCTT,delATTCTT,O
gene,gene,O
site,site,O
the,from,O
termination,termination,O
3,3,O
part,part,O
and,2,O
the,the,O
in,polymorphism,O
in,the,O
were,were,O
upstream,upstream,O
promotor,promotor,O
gene,gene,O
142,142,O
CPO,CPO,O
",",",",O
The,The,O
,,
degree,degree,O
mutations,different,O
characterized,now,O
high,the,O
intragenic,dimorphisms,O
allelic,allelic,O
.,.,O
and,and,O
is,is,O
so,so,O
.,.,O
well,well,O
the,high,O
defects,defects,I
seven,seven,O
are,are,O
different,mutations,O
far,far,O
making,making,O
in,in,O
new,new,O
nineteen,nineteen,O
Five,Five,O
of,of,O
CPO,reported,O
heterogeneity,heterogeneity,O
demonstrated,with,O
gene,gene,B
of,of,O
reported,CPO,O
with,demonstrated,O
HC,HC,B
a,a,O
dimorphisms,intragenic,O
total,total,O
now,characterized,O
,,
within,within,O
of,basis,O
>,>,O
arylsulfatase,A,O
459,459,O
novel,novel,O
.,.,O
of,two,O
heterogeneity,heterogeneity,O
A,1G,O
:,:,O
alleles,alleles,O
two,coincidence,O
leukodystrophy,leukodystrophy,I
metachromatic,metachromatic,B
a,a,O
basis,of,O
1G,A,O
and,and,O
with,with,O
+,+,O
mutation,mutation,O
molecular,molecular,O
Coincidence,Of,O
family,family,O
phenotypic,phenotypic,O
A,arylsulfatase,O
,,
leukodystrophy,leukodystrophy,I
galactosylsulfatide,GS,O
(,(,O
years,with,O
),),O
family,with,O
and,and,O
(,(,O
three,three,O
age,at,O
),),O
increased,increased,O
),),O
In,In,O
siblings,siblings,O
",",",",O
a,a,O
A,A,O
",",",",O
arylsulfatase,deficient,O
deficient,arylsulfatase,O
with,5,O
infantile,fatal,O
developed,one,O
fatal,infantile,O
one,developed,O
metachromatic,metachromatic,B
GS,galactosylsulfatide,O
classical,late,O
ARSA,ARSA,O
",",",",O
activity,activity,O
excretion,excretion,O
at,age,O
late,classical,O
5,years,O
.,.,O
MLD,MLD,B
(,(,O
with,family,O
,,
",",",",O
two,other,O
at,12,O
as,well,O
and,and,O
/,/,O
apparently,apparently,O
and,2,O
1,at,O
MLD,MLD,B
father,father,O
12,1,O
values,within,O
),),O
",",",",O
years,years,O
respectively,respectively,O
(,(,O
patients,patients,O
of,of,O
healthy,healthy,O
apparently,siblings,O
presented,presented,O
",",",",O
",",",",O
ARSA,ARSA,O
",",",",O
within,values,O
healthy,healthy,O
GS,GS,O
The,The,O
15,15,O
well,as,O
2,and,O
their,their,O
range,the,O
the,range,O
.,.,O
siblings,apparently,O
other,two,O
and,and,O
,,
mutations,mutations,O
different,different,O
Mutation,Screening,O
molecular,the,O
.,.,O
sequence,sequence,O
ARSA,ARSA,O
phenotypic,heterogeneity,O
heterogeneity,intrafamilial,O
basis,basis,O
of,phenotypic,O
and,and,O
disclosed,disclosed,O
being,being,O
screening,mutation,O
three,three,O
analysis,analysis,O
the,the,O
involvement,involvement,O
the,molecular,O
intrafamilial,of,O
of,of,O
,,
1G,459,O
at,guanine,O
.,.,O
his,from,O
nucleotide,7,O
microdeletion,of,O
a,a,O
in,in,O
7,at,O
-,-,O
The,The,O
>,>,O
),),O
type,mutation,O
novel,novel,O
1,1,O
",",",",O
inherited,inherited,O
exon,exon,O
guanine,nucleotide,O
(,(,O
infantile,infantile,O
7delG,7delG,O
late,late,O
single,single,O
from,from,O
patient,patient,O
459,1G,O
mutation,type,O
and,his,O
",",",",O
+,+,O
basepair,basepair,O
0,0,O
frequent,frequent,O
the,mother,O
father,father,O
of,microdeletion,O
mother,the,O
A,and,O
from,A,O
his,his,O
,,
transition,at,O
alanine,of,O
",",",",O
unaffected,clinically,O
),),O
their,their,O
+,+,O
to,to,O
exon,8,O
two,two,O
cytosine,novel,O
paternal,paternal,O
on,on,O
nucleotide,2435,O
substitution,substitution,O
1G,459,O
8,exon,O
novel,cytosine,O
maternal,maternal,O
the,the,O
allele,allele,O
thymidine,thymidine,O
clinically,unaffected,O
by,by,O
siblings,siblings,O
at,transition,O
carried,carried,O
A,A,O
A464V,A464V,O
of,464,O
464,alanine,O
",",",",O
mutation,mutation,O
459,1G,O
a,a,O
>,>,O
(,(,O
in,in,O
valine,valine,O
The,The,O
resulting,resulting,O
and,and,O
",",",",O
2435,nucleotide,O
in,in,O
.,.,O
,,
thus,thus,O
The,The,O
A464V,was,O
fathers,genotype,O
/,/,O
.,.,O
7delG,A464V,O
was,7delG,O
genotype,fathers,O
,,
patients,and,O
controls,controls,O
and,patients,O
was,A464V,O
.,.,O
18,18,O
unrelated,unrelated,O
found,found,O
MLD,MLD,B
in,in,O
A464V,was,O
Mutation,Mutation,O
not,not,O
50,50,O
,,
ARSA,ARSA,O
of,mimicking,O
manifestation,manifestation,O
",",",",O
bears,bears,O
",",",",O
clinical,clinical,O
and,and,O
frequent,frequent,O
pseudodeficiency,pseudodeficiency,O
mimicking,of,O
A464V,A464V,O
levels,apparently,O
modifying,modifying,O
MLD,MLD,B
the,the,O
apparently,levels,O
ARSA,ARSA,O
.,.,O
although,although,O
allele,allele,O
GS,GS,O
",",",",O
little,significance,O
significance,little,O
clearly,clearly,O
for,for,O
,,
and,and,O
serious,serious,O
in,that,O
Our,Results,O
ARSA,ARSA,O
certain,certain,O
-,-,O
values,values,O
not,not,O
",",",",O
prognostic,implications,O
implications,prognostic,O
with,finding,O
GS,GS,O
genetic,conditions,O
MLD,MLD,B
finding,with,O
clinical,clinical,O
diagnostic,diagnostic,O
results,our,O
need,need,O
and,and,O
a,disease,O
disease,a,O
.,.,O
paralleled,by,O
conditions,genetic,O
that,in,O
be,be,O
like,like,O
demonstrate,demonstrate,O
by,paralleled,O
,,
outbreak,outbreak,O
together,with,O
but,but,O
which,exist,O
type,0,O
may,mutations,O
not,not,O
might,might,O
-,-,O
mutations,may,O
disease,disease,O
",",",",O
Moreover,Moreover,O
",",",",O
the,the,O
pathological,pathological,O
of,of,O
ARSA,ARSA,O
alleles,functionally,O
GS,levels,O
.,.,O
cause,cause,O
functionally,alleles,O
clinical,clinical,O
with,together,O
to,A464V,O
and,and,O
levels,GS,O
0,type,O
exist,which,O
.,.,O
similar,similar,O
further,further,O
ARSA,ARSA,O
",",",",O
A464V,to,O
",",",",O
,,
predisposes,to,O
and,and,O
to,predisposes,O
neurofibromatosis,neurofibromatosis,B
MLH1,deficiency,O
hematological,hematological,B
malignancy,malignancy,I
.,.,O
1,1,I
type,type,I
deficiency,MLH1,O
Human,Human,O
,,
line,mutations,O
DNA,DNA,O
to,lead,O
germ,heterozygous,O
genes,genes,O
lead,to,O
Heterozygous,Germ,O
colorectal,colorectal,I
nonpolyposis,nonpolyposis,I
mismatch,mismatch,O
mutations,in,O
cancer,cancer,I
the,the,O
repair,repair,O
in,line,O
.,.,O
-,-,O
hereditary,hereditary,B
,,
.,.,O
both,both,O
disease,disease,O
is,alleles,O
alleles,is,O
of,individuals,O
The,The,O
-,-,O
constitutionally,who,O
unknown,unknown,O
wild,type,O
individuals,constitutionally,O
lack,lack,O
susceptibility,susceptibility,O
who,of,O
type,wild,O
,,
signs,signs,O
hematological,hematological,B
1,1,I
of,of,O
),),O
displayed,them,O
early,a,O
have,have,O
at,at,O
three,three,O
NF1,NF1,B
nonpolyposis,nonpolyposis,I
neurofibromatosis,neurofibromatosis,B
We,We,O
type,type,I
in,in,O
two,two,O
a,a,O
offspring,offspring,O
.,.,O
identified,identified,O
a,very,O
at,at,O
family,family,O
and,and,O
very,early,O
",",",",O
them,displayed,O
who,who,O
colorectal,colorectal,I
hereditary,hereditary,B
age,age,O
developed,developed,O
(,(,O
cancer,cancer,I
of,least,O
malignancy,malignancy,I
least,of,O
,,
specific,specific,O
Arg226Stop,C676T,O
sequence,sequence,O
-,-,O
analysis,analysis,O
(,(,O
>,>,O
),),O
.,.,O
C676T,Arg226Stop,O
-,-,O
MLH1,mutation,O
amplification,in,O
a,revealed,O
revealed,two,O
DNA,DNA,O
mutation,MLH1,O
siblings,a,O
-,-,O
in,amplification,O
homozygous,homozygous,O
two,siblings,O
and,and,O
allele,allele,O
,,
MLH1,MLH1,O
with,with,O
mismatch,repair,O
.,.,O
deficiency,mismatch,O
results,results,O
.,.,O
leukemia,leukemia,B
repair,deficiency,O
phenotype,phenotype,O
mutation,and,O
characterized,by,O
neurofibromatosis,neurofibromatosis,B
consequent,consequent,O
by,and,O
Thus,Thus,O
mutator,a,O
lymphoma,lymphoma,B
a,a,O
-,-,O
a,mutator,O
1,1,I
type,type,I
or,or,O
associated,associated,O
line,line,O
/,/,O
",",",",O
and,characterized,O
in,in,O
and,mutation,O
germ,homozygous,O
homozygous,germ,O
,,
PAX6,PAX6,O
of,of,O
.,.,O
congenital,congenital,B
residues,most,O
of,human,O
in,mutations,O
a,underlie,O
eye,eye,I
the,the,O
mutations,in,O
spectrum,of,O
domain,domain,O
human,spectrum,O
most,ancient,O
the,the,O
underlie,a,O
paired,paired,O
ancient,residues,O
malformations,malformations,I
Missense,Missense,O
,,
of,of,I
aniridia,aniridia,B
of,of,O
gene,underlie,O
the,the,I
the,the,O
absence,absence,I
of,of,I
eye,eye,I
a,a,O
the,the,I
human,PAX6,O
rare,dominant,O
iris,iris,I
Mutations,Mutations,O
.,.,O
),),O
PAX6,human,O
malformation,malformation,B
(,(,O
dominant,rare,O
underlie,gene,O
congenital,congenital,B
",",",",O
,,
%,%,O
92,of,O
2,2,O
",",",",O
just,just,O
truncation,truncation,O
),),O
substitution,substitution,O
and,and,O
.,.,O
PAX6,PAX6,O
",",",",O
mutations,mutations,O
is,is,O
(,(,O
aniridia,aniridia,B
all,all,O
patients,patients,O
spectrum,spectrum,O
the,of,O
missense,another,O
of,the,O
leading,leading,O
one,amino,O
%,%,O
amino,one,O
and,and,O
by,by,O
another,missense,O
(,(,O
),),O
in,in,O
reported,reported,O
splicing,insertions,O
of,92,O
protein,protein,O
highly,highly,O
",",",",O
premature,premature,O
to,leading,O
of,of,O
acid,acid,O
nonsense,nonsense,O
to,to,O
The,The,O
of,of,O
deletions,deletions,O
leading,to,O
biased,biased,O
with,with,O
insertions,splicing,O
mutations,mutations,O
,,
even,though,O
in,should,O
PAX6,PAX6,O
protein,the,O
missense,mutations,O
they,they,O
.,.,O
patients,patients,O
common,common,O
in,in,O
hardly,hardly,O
extraordinary,the,O
seen,seen,O
mutations,missense,O
level,amongst,O
be,fact,O
predicts,vertebrates,O
pathological,pathological,O
The,Extraordinary,O
of,of,O
vertebrates,predicts,O
are,are,O
ever,ever,O
the,at,O
conservation,conservation,O
amino,amino,O
fact,in,O
though,even,O
at,protein,O
the,the,O
that,that,O
should,be,O
amongst,level,O
aniridia,aniridia,B
acid,acid,O
,,
from,distinct,O
.,.,O
bias,ascertainment,O
textbook,textbook,O
is,is,O
that,that,O
indicates,indicates,O
mutations,may,O
mutation,mutation,O
This,This,O
ascertainment,bias,O
analysis,analysis,O
of,of,O
that,and,O
the,the,O
aniridia,aniridia,B
PAX6,PAX6,O
frequently,missense,O
and,that,O
selection,selection,O
patients,for,O
underlie,underlie,O
for,patients,O
the,the,O
phenotypes,phenotypes,O
distinct,from,O
PAX6,missing,O
there,there,O
missense,mutations,O
may,frequently,O
in,in,O
missing,PAX6,O
heavy,heavy,O
a,a,O
,,
mutations,mutations,O
in,in,O
we,present,O
more,association,O
and,and,O
two,two,O
present,here,O
PAX6,PAX6,O
),),O
searching,searching,B
association,with,O
(,(,O
aniridia,aniridia,B
association,association,O
phenotypes,phenotypes,O
missense,missense,O
with,with,O
and,and,O
displaced,displaced,B
two,two,O
),),O
congenital,congenital,B
with,more,O
phenotypes,phenotypes,O
pupillae,pupillae,I
.,.,O
pupils,pupils,I
nystagmus,nystagmus,I
gaze,gaze,I
novel,novel,O
Here,We,O
",",",",O
in,in,O
(,(,O
ectopia,ectopia,B
atypical,atypical,O
",",",",O
recognizable,recognizable,O
four,four,O
,,
known,known,O
the,the,O
within,within,O
paired,paired,O
all,all,O
located,located,O
domain,domain,O
are,mutations,O
mutations,are,O
all,all,O
and,and,O
.,.,O
domain,domain,O
four,four,O
highly,are,O
paired,paired,O
PAX6,PAX6,O
proteins,proteins,O
Strikingly,Strikingly,O
conserved,conserved,O
which,highly,O
affect,affect,O
",",",",O
in,in,O
acids,which,O
are,acids,O
amino,amino,O
,,
related,related,I
burden,substantial,O
to,to,O
and,bias,O
support,results,O
remains,remains,O
by,by,O
that,hypothesis,O
under,under,O
representation,representation,O
ascertainment,ascertainment,O
of,missense,O
-,-,O
the,the,O
Our,Our,O
hypothesis,that,O
suggest,that,O
bias,and,O
uncovered,uncovered,O
PAX6,PAX6,B
results,support,O
-,-,I
.,.,O
caused,is,O
missense,of,O
.,.,O
is,caused,O
the,the,O
disease,disease,I
mutations,mutations,O
of,of,O
that,suggest,O
a,a,O
substantial,burden,O
be,be,O
,,
second,second,I
deficiency,deficiency,B
of,of,I
The,The,O
factor,factor,O
component,component,I
of,controlling,O
major,major,O
.,.,O
chromosomal,chromosomal,O
complement,complement,I
controlling,genes,O
",",",",O
histocompatibility,complex,O
complex,properdin,O
the,the,I
and,B,O
the,the,O
of,of,I
",",",",O
order,order,O
B,and,O
properdin,histocompatibility,O
genes,of,O
,,
for,for,O
coding,genes,O
the,the,I
disorders,disorders,O
genes,the,O
B,B,O
(,(,O
coding,those,O
for,HLA,O
second,second,I
patients,patients,O
for,C2,O
),),O
those,coding,O
deficiency,deficiency,B
HLA,for,O
Factor,Factor,O
the,coding,O
in,families,O
of,of,I
C2,for,O
tissue,tissue,O
families,in,O
component,component,I
properdin,properdin,O
complement,complement,I
relationship,relationship,O
studied,studied,O
of,of,O
with,connective,O
was,was,O
to,to,O
.,.,O
of,of,I
connective,with,O
The,The,O
and,and,O
of,of,O
allotypes,allotypes,O
,,
they,because,O
.,.,O
deficiency,deficiency,I
Patients,Were,O
or,or,O
were,patients,O
were,were,O
C2,C2,B
for,homozygous,O
selected,selected,O
heterozygous,heterozygous,O
because,they,O
homozygous,for,O
,,
deficiency,deficiency,I
12,12,O
were,found,O
for,were,O
.,.,O
informative,informative,O
matings,matings,O
found,for,O
with,15,O
C2,C2,B
families,families,O
15,with,O
,,
with,with,O
and,HLA,O
a,recombinant,O
57,57,O
.,.,O
fraction,of,O
were,crossovers,O
two,two,O
C2,C2,B
the,and,O
",",",",O
the,between,O
",",",",O
noted,the,O
Of,Of,O
0,0,O
between,noted,O
crossovers,were,O
informative,informative,O
gene,gene,O
of,fraction,O
-,-,O
gene,gene,O
recombinant,a,O
meioses,meioses,O
deficiency,deficiency,I
HLA,the,O
B,B,O
,,
.,.,O
035,035,O
,,
of,lod,O
recombinant,recombinant,O
13,was,O
maximum,likelihood,O
HLA,HLA,O
between,and,O
at,a,O
calculated,calculated,O
lod,a,O
value,value,O
linkage,for,O
fraction,fraction,O
B,B,O
of,of,O
of,of,O
C2,C2,B
score,of,O
0,0,O
a,at,O
for,linkage,O
likelihood,maximum,O
-,-,O
.,.,O
A,Score,O
the,the,O
and,between,O
was,13,O
deficiency,deficiency,I
,,
04,04,O
.,.,O
,,
for,for,O
properdin,properdin,O
both,both,O
B,HLA,O
-,-,O
HLA,B,O
B,B,O
with,21,O
Factor,Factor,O
18,18,O
found,were,O
.,.,O
were,found,O
families,families,O
and,and,O
matings,informative,O
allotype,allotype,O
informative,matings,O
21,with,O
,,
found,were,O
",",",",O
a,a,O
informative,72,O
.,.,O
giving,giving,O
",",",",O
Of,Informative,O
72,of,O
were,found,O
of,0,O
0,of,O
recombinants,recombinants,O
recombinant,fraction,O
three,three,O
meioses,meioses,O
fraction,recombinant,O
,,
.,.,O
042,042,O
,,
value,likelihood,O
and,Factor,O
a,maximum,O
-,-,O
A,Lod,O
.,.,O
the,of,O
recombinant,the,O
B,B,O
HLA,HLA,O
was,was,O
allotypes,allotypes,O
16,16,O
at,at,O
0,0,O
maximum,a,O
fraction,recombinant,O
of,of,O
calculated,calculated,O
score,a,O
between,between,O
Factor,and,O
B,B,O
likelihood,value,O
of,fraction,O
of,of,O
lod,score,O
,,
04,04,O
.,.,O
,,
and,B,O
.,.,O
A,A,O
crossover,was,O
A,A,O
for,for,O
",",",",O
D,D,O
-,-,O
have,have,O
genes,genes,O
between,occurred,O
-,-,O
D,D,O
to,to,O
occurred,between,O
HLA,B,O
shown,shown,O
HLA,which,O
B,and,O
which,HLA,O
Factor,Factor,O
in,in,O
with,with,O
B,and,O
HLA,HLA,O
segregared,segregared,O
was,crossover,O
and,HLA,O
-,-,O
,,
that,that,O
C2,C2,B
proximity,close,O
HLA,HLA,O
of,lack,O
",",",",O
",",",",O
the,that,O
these,these,O
5,5,O
suggests,suggests,O
B,B,O
another,another,O
in,in,O
that,that,O
HLA,HLA,O
-,-,O
located,located,O
HLA,HLA,O
",",",",O
approximately,approximately,O
and,and,O
deficiency,deficiency,I
C2,C2,B
",",",",O
the,that,O
lack,of,O
genese,genese,O
one,one,O
B,B,O
allotype,allotype,O
genes,genes,O
",",",",O
outside,outside,O
These,These,O
genes,the,O
the,the,O
close,proximity,O
",",",",O
Factor,Factor,O
that,the,O
deficiency,deficiency,I
HLA,HLA,O
A,A,O
are,allotypes,O
and,and,O
gene,gene,O
deficiency,deficiency,I
B,B,O
B,B,O
studies,studies,O
D,D,O
C2,C2,B
the,genes,O
recombinants,recombinants,O
-,-,O
.,.,O
genes,genes,O
for,for,O
suggest,suggest,O
deficiency,deficiency,I
that,that,O
B,Factor,O
Factor,Factor,O
order,order,O
and,and,O
centimorgans,centimorgans,O
those,those,O
from,from,O
B,B,O
A,A,O
to,to,O
and,are,O
",",",",O
between,between,O
C2,C2,B
of,of,O
Factor,B,O
-,-,O
loci,loci,O
lie,lie,O
the,the,O
and,and,O
are,and,O
Factor,Factor,O
-,-,O
two,two,O
-,-,O
-,-,O
for,for,O
allotypes,are,O
-,-,O
for,for,O
the,the,O
3,3,O
coding,coding,O
apparent,apparent,O
gene,gene,O
is,is,O
that,the,O
,,
implications,implications,O
dystrophy,dystrophy,I
and,emerin,O
lamins,in,O
muscular,muscular,I
heart,heart,O
of,and,O
Emery,Emery,B
.,.,O
Dreifuss,Dreifuss,I
and,and,O
emerin,distribution,O
in,lamins,O
Distribution,Of,O
for,for,O
-,-,I
the,the,O
,,
a,nuclear,O
is,is,O
is,is,O
in,defective,O
EDMD,EDMD,B
defective,in,O
missing,missing,O
.,.,O
membrane,membrane,O
Emery,Emery,B
dystrophy,dystrophy,I
protein,protein,O
-,-,I
),),O
which,which,O
or,or,O
muscular,muscular,I
nuclear,a,O
Dreifuss,Dreifuss,I
(,(,O
Emerin,Emerin,O
,,
family,family,O
It,Is,O
B,receptor,O
-,-,O
LAP2,LAP2,O
(,(,O
lamin,and,O
proteins,proteins,O
member,member,O
lamina,lamina,O
of,of,O
is,it,O
associated,associated,O
a,a,O
of,of,O
one,one,O
and,lamin,O
includes,LAP1,O
.,.,O
which,includes,O
),),O
",",",",O
LBR,B,O
LAP1,which,O
receptor,LBR,O
,,
emerin,emerin,O
panel,panel,O
of,of,O
localize,localize,O
specific,specific,O
and,rabbit,O
displayed,phage,O
human,human,O
molecule,molecule,O
mAbs,antibodies,O
and,and,O
been,been,O
16,16,O
in,in,O
has,has,O
using,emerin,O
mapped,mapped,O
to,used,O
emerin,using,O
A,A,O
used,to,O
phage,displayed,O
(,(,O
-,-,O
has,has,O
throughout,throughout,O
libraries,peptide,O
six,six,O
),),O
.,.,O
the,the,O
peptide,libraries,O
antibodies,mAbs,O
monoclonal,monoclonal,O
to,to,O
been,been,O
heart,heart,O
rabbit,and,O
sites,sites,O
,,
",",",",O
Several,Several,O
though,though,O
recognized,recognized,O
against,mAbs,O
in,discs,O
nuclei,strongly,O
",",",",O
mAbs,against,O
both,at,O
or,or,O
in,spots,O
recognize,recognize,O
.,.,O
the,the,O
epitopes,epitopes,O
not,not,O
did,did,O
heart,the,O
spots,in,O
strongly,nuclei,O
intercalated,intercalated,O
emerin,emerin,O
rim,rim,O
they,they,O
and,intranuclear,O
intranuclear,and,O
channels,channels,O
different,different,O
discs,in,O
cardiomyocyte,cardiomyocyte,O
the,heart,O
at,both,O
,,
on,on,O
but,but,O
band,emerin,O
recognize,recognize,O
.,.,O
only,only,O
blot,blot,O
membrane,membrane,O
polyclonal,polyclonal,O
after,after,O
affinity,purification,O
",",",",O
pure,a,O
and,membrane,O
nuclear,and,O
purification,affinity,O
a,pure,O
a,a,O
it,it,O
stained,stained,O
-,-,O
emerin,against,O
did,did,O
rabbit,rabbit,O
antiserum,antiserum,O
the,the,O
against,against,O
",",",",O
emerin,band,O
intercalated,intercalated,O
against,emerin,O
western,western,O
discs,discs,O
nuclear,nuclear,O
A,A,O
both,both,O
membrane,nuclear,O
,,
EDMD,EDMD,B
doubt,doubt,O
that,that,O
results,results,O
",",",",O
were,discs,O
cast,therefore,O
are,in,O
immunostaining,immunostaining,O
due,due,O
product,product,O
gene,gene,O
of,of,O
These,These,O
intercalated,emerin,O
",",",",O
emerin,of,O
hypothesis,the,O
absence,absence,O
not,be,O
discs,discs,O
of,from,O
would,would,O
defects,defects,I
and,and,O
caused,caused,O
.,.,O
to,to,O
some,some,O
at,at,O
intercalated,intercalated,O
the,the,O
therefore,cast,O
emerin,emerin,O
from,intercalated,O
cardiac,cardiac,B
by,by,O
upon,upon,O
the,hypothesis,O
a,a,O
in,are,O
expected,expected,O
be,not,O
discs,were,O
if,if,O
,,
it,was,O
.,.,O
from,from,O
emerin,although,O
was,was,O
was,it,O
the,the,O
-,-,O
cells,non,O
the,heart,O
Although,Emerin,O
nuclei,nuclei,O
cardiomyocyte,of,O
in,in,O
many,many,O
abundant,abundant,O
",",",",O
heart,in,O
of,cardiomyocyte,O
absent,absent,O
myocyte,cells,O
in,the,O
membranes,membranes,O
non,myocyte,O
,,
similar,to,O
to,similar,O
of,this,O
an,an,O
lamin,lamin,O
of,of,O
EDMD,EDMD,B
emerin,was,O
This,Distribution,O
candidate,candidate,O
form,form,O
A,A,O
that,that,O
",",",",O
for,gene,O
of,of,O
was,of,O
distribution,emerin,O
autosomal,autosomal,O
gene,for,O
.,.,O
a,a,O
,,
localization,for,O
cardiomyocyte,cardiomyocyte,O
lamin,lamin,O
from,from,O
emerin,of,O
lamin,B1,O
not,not,O
contrast,contrast,O
B1,lamin,O
In,In,O
for,localization,O
lamina,to,O
essential,essential,O
showing,that,O
B1,B1,O
nuclei,nuclei,O
that,showing,O
to,emerin,O
",",",",O
the,nuclear,O
absent,absent,O
was,was,O
is,is,O
",",",",O
nuclear,lamina,O
of,the,O
.,.,O
,,
nuclei,muscle,O
is,is,O
muscle,nuclei,O
almost,almost,O
B1,lamin,O
also,also,O
completely,from,O
absent,completely,O
from,absent,O
skeletal,skeletal,O
Lamin,B1,O
.,.,O
,,
",",",",O
why,why,O
are,particularly,O
which,which,O
of,absence,O
may,emerin,O
.,.,O
.,.,O
B1,from,O
and,heart,O
heart,and,O
EDMD,EDMD,B
explanation,of,O
additional,additional,O
already,already,O
these,tissues,O
offer,offer,O
skeletal,nuclei,O
an,an,O
from,B1,O
lack,lack,O
lamin,lamin,O
the,the,O
absence,of,O
of,explanation,O
tissues,these,O
alternative,alternative,O
affected,affected,O
In,In,O
nuclei,muscle,O
muscle,skeletal,O
emerin,may,O
particularly,are,O
,,
p16,region,O
terriers,Bedlington,O
10,chromosome,O
the,the,O
toxicosis,toxicosis,I
in,in,O
to,to,O
mapping,genetic,O
Genetic,Mapping,O
",",",",O
region,2p13,O
in,in,O
2p13,p16,O
human,human,O
of,of,O
to,syntenic,O
region,to,O
copper,copper,B
chromosome,chromosome,O
.,.,O
syntenic,region,O
chromosome,10,O
locus,locus,O
a,a,O
Bedlington,terriers,O
dog,dog,O
-,-,O
,,
as,as,O
",",",",O
is,recognized,O
disorder,disorder,I
copper,copper,I
rat,rat,O
in,an,O
dog,dog,O
an,in,O
accumulation,accumulation,I
",",",",O
Abnormal,Is,O
hepatic,hepatic,B
man,mouse,O
.,.,O
mouse,man,O
recognized,abnormal,O
inherited,inherited,B
and,and,O
,,
The,Major,O
accumulation,accumulation,I
copper,copper,I
WD,WD,B
major,the,O
hepatic,hepatic,B
(,(,O
Wilson,Wilson,B
in,of,O
gene,causing,O
dysfunctional,dysfunctional,O
is,man,O
a,a,O
),),O
",",",",O
man,is,O
of,in,O
disease,disease,I
ATP7B,ATP7B,O
causing,gene,O
.,.,O
cause,cause,O
,,
rat,rat,O
been,also,O
genes,genes,O
have,have,O
and,mouse,O
Mutations,Mutations,O
demonstrated,demonstrated,O
.,.,O
mouse,and,O
in,in,O
in,in,O
the,the,O
also,been,O
ATP7B,ATP7B,O
,,
much,human,O
copper,copper,B
overload,overload,I
ATP7B,ATP7B,O
The,The,O
human,rarer,O
been,been,O
the,the,O
childhood,childhood,I
cirrhosis,cirrhosis,I
non,non,B
has,gene,O
Indian,Indian,I
excluded,in,O
genetic,genetic,O
.,.,O
-,-,I
indicating,disease,O
heterogeneity,heterogeneity,O
rarer,much,O
",",",",O
disease,indicating,O
in,excluded,O
gene,has,O
,,
disease,disease,I
Bedlington,Bedlington,O
progressive,in,O
copper,copper,B
the,the,O
(,(,O
locus,locus,O
new,new,O
CT,CT,B
.,.,O
toxicosis,toxicosis,I
),),O
recessive,autosomal,O
in,in,O
a,identified,O
autosomal,recessive,O
in,progressive,O
By,By,O
identified,a,O
liver,liver,B
investigating,investigating,O
terriers,we,O
common,common,O
have,have,O
we,terriers,O
involved,involved,O
",",",",O
,,
co,co,O
CT,CT,B
WD,WD,B
in,in,O
ATP7B,was,O
whether,whether,O
C04107,C04107,O
gene,gene,O
also,causative,O
the,the,O
examined,examined,O
causative,also,O
investigating,by,O
(,(,O
.,.,O
was,ATP7B,O
We,We,O
ATP7B,and,O
hybridization,FISH,O
),),O
-,-,O
FISH,hybridization,O
the,the,O
chromosomal,chromosomal,O
using,fluorescence,O
for,for,O
localization,localization,O
situ,situ,O
of,of,O
by,investigating,O
and,ATP7B,O
fluorescence,using,O
",",",",O
,,
is,is,O
anonymous,anonymous,O
an,an,O
CT,CT,B
to,linked,O
marker,microsatellite,O
microsatellite,marker,O
closely,to,O
.,.,O
C04107,C04107,O
linked,closely,O
,,
WD,WD,B
that,that,O
to,to,O
and,and,O
chromosome,chromosome,O
clones,clones,O
demonstrating,respectively,O
cannot,can,O
the,to,O
regions,regions,O
ATP7B,and,O
CFA10q26,CFA10q26,O
",",",",O
homologous,be,O
canine,canine,O
However,However,O
CFA22q11,CFA22q11,O
be,not,O
respectively,demonstrating,O
to,the,O
.,.,O
and,ATP7B,O
mapped,C04107,O
containing,containing,O
C04107,mapped,O
BAC,BAC,O
",",",",O
CT,CT,B
",",",",O
,homologous,
,,
to,to,O
also,also,O
as,as,O
mapped,they,O
The,Transport,O
since,since,O
for,for,O
genes,genes,O
chromosome,region,O
candidate,genes,O
were,CTR2,O
.,.,O
excluded,excluded,O
genes,candidate,O
transport,copper,O
copper,the,O
region,chromosome,O
both,mapped,O
they,both,O
CTR2,were,O
CT,CT,B
canine,canine,O
CFA11q22,CFA11q22,O
and,and,O
CTR1,CTR1,O
,,
22,2,O
-,-,O
.,.,O
2,22,O
,,
.,.,O
5,5,O
,,
containing,containing,O
2p13,p16,O
p16,a,O
sequence,sequence,O
.,.,O
from,C04107,O
",",",",O
found,found,O
gene,gene,O
any,positional,O
from,expressed,O
the,identified,O
expressed,from,O
to,a,O
genes,genes,O
identified,the,O
BAC,BAC,O
homologous,homologous,O
-,-,O
chromosome,chromosome,O
to,to,O
transcribed,transcribed,O
was,was,O
-,-,O
candidate,candidate,O
be,be,O
A,A,O
positional,any,O
devoid,region,O
a,to,O
a,2p13,O
human,human,O
of,of,O
region,devoid,O
C04107,from,O
,,
Molecular,Analysis,O
in,in,O
-,-,O
APC,APC,B
evidence,evidence,O
the,gene,O
families,in,O
acid,acid,O
colorectal,colorectal,B
gene,the,O
in,extended,O
genotype,genotype,O
role,role,O
for,the,O
phenotype,correlations,O
changes,changes,O
correlations,phenotype,O
of,of,O
the,for,O
FAP,FAP,B
in,in,O
cancer,cancer,I
amino,amino,O
:,:,O
.,.,O
205,205,O
predisposition,predisposition,O
of,of,O
extended,families,O
and,and,O
analysis,molecular,O
APC,APC,B
,,
APC,APC,B
/,/,O
familial,familial,B
dominant,dominant,O
FAP,FAP,B
),),O
of,of,O
adenomatous,adenomatous,I
a,a,O
mutations,gene,O
result,result,O
range,of,O
the,is,O
coli,coli,I
gene,mutations,O
polyposis,polyposis,I
(,(,O
extracolonic,extracolonic,O
development,of,O
of,the,O
cancer,cancer,I
The,The,O
),),O
of,development,O
and,and,O
BACKGROUND,BACKGROUND,O
the,of,O
inheritance,inheritance,O
of,range,O
polyposis,polyposis,I
colorectal,colorectal,B
variable,variable,O
manifestations,manifestations,O
is,the,O
.,.,O
adenomatous,adenomatous,B
(,(,O
AIMS,AIMS,O
in,in,O
,,
FAP,in,O
nine,nine,O
colorectal,colorectal,B
.,.,O
for,for,O
to,performed,O
phenotype,phenotype,O
mutation,analysis,O
study,study,O
this,in,O
performed,to,O
extracolonic,manifestations,O
In,This,O
incidence,incidence,O
mutations,mutations,O
the,the,O
APC,APC,B
non,FAP,O
-,-,O
in,non,O
correlations,correlations,O
determine,determine,O
manifestations,extracolonic,O
direct,mutation,O
gene,was,O
investigate,investigate,O
to,and,O
the,the,O
of,of,O
of,of,O
and,to,O
genotype,genotype,O
-,-,O
analysis,direct,O
APC,APC,B
was,gene,O
cancer,cancer,I
",",",",O
,,
190,in,O
denaturing,denaturing,O
analysed,analysed,O
FAP,FAP,B
15,15,O
sequencing,sequencing,O
was,gene,O
test,test,O
patients,using,O
protein,truncation,O
gradient,gradient,O
in,190,O
electrophoresis,the,O
The,was,O
and,and,O
using,patients,O
gene,The,O
",",",",O
and,and,O
.,.,O
non,FAP,O
gel,electrophoresis,O
cancer,cancer,I
APC,APC,B
-,-,O
unrelated,unrelated,O
the,gel,O
FAP,non,O
METHODS,METHODS,O
colorectal,colorectal,B
direct,direct,O
",",",",O
truncation,protein,O
,,
(,(,O
Chain,RESULTS,O
patients,in,O
.,.,O
in,patients,O
group,group,O
),),O
to,to,O
RESULTS,Chain,O
belonging,belonging,O
identified,identified,O
the,the,O
were,only,O
only,were,O
105,105,O
patients,patients,O
terminating,terminating,O
FAP,FAP,B
signals,signals,O
,,
belonged,belonged,O
colorectal,colorectal,B
whom,whom,O
changes,acid,O
patients,three,O
Amino,Amino,O
-,-,O
non,FAP,O
three,patients,O
group,of,O
of,of,O
.,.,O
in,four,O
the,the,O
four,in,O
patients,patients,O
identified,identified,O
FAP,non,O
to,to,O
were,changes,O
",",",",O
of,group,O
acid,were,O
cancer,cancer,I
,,
-,-,O
to,to,O
phenotype,genotype,O
manifestations,extracolonic,O
in,in,O
the,nature,O
belonging,patients,O
three,three,O
correlations,correlations,O
FAP,FAP,B
identified,identified,O
patients,belonging,O
nature,the,O
of,of,O
extracolonic,manifestations,O
Genotype,Phenotype,O
mutation,mutation,O
significant,significant,O
certain,certain,O
.,.,O
in,in,O
subgroups,subgroups,O
differences,differences,O
,,
associated,with,O
have,potential,O
with,mutations,O
the,have,O
potential,the,O
conditions,threatening,O
threatening,conditions,O
made,made,O
-,-,O
for,for,O
correlations,correlations,O
to,to,O
surveillance,surveillance,O
genotype,genotype,O
study,study,O
the,the,O
.,.,O
patients,patients,O
regimens,regimens,O
appropriate,most,O
and,and,O
this,this,O
prophylactic,prophylactic,O
may,may,O
those,those,O
phenotype,phenotype,O
in,in,O
treatment,treatment,O
CONCLUSIONS,Extended,O
Extended,CONCLUSIONS,O
with,life,O
mutations,with,O
determine,determine,O
most,appropriate,O
life,associated,O
,,
FAP,FAP,B
acid,acid,O
APC,associated,O
.,.,O
non,non,O
colorectal,colorectal,B
.,.,O
nature,nature,O
evidence,evidence,O
patients,patients,O
of,of,O
associated,with,O
for,for,O
changes,changes,O
also,provided,O
and,both,O
in,in,O
the,the,O
pathological,pathological,O
provided,also,O
amino,amino,O
This,Study,O
FAP,FAP,O
study,this,O
-,-,O
cancer,cancer,I
both,and,O
with,APC,O
,,
the,the,O
.,.,O
risk,and,O
polyposis,polyposis,I
and,risk,O
of,of,O
polymorphism,polymorphism,O
Inherited,Inherited,B
colorectal,colorectal,I
APC,APC,O
I1307K,I1307K,O
cancer,cancer,B
,,
",",",",O
are,gene,O
respectively,respectively,O
syndrome,syndrome,I
to,to,O
-,-,O
carcinogenesis,carcinogenesis,O
.,.,O
and,and,O
sporadic,colorectal,O
adenomatous,adenomatous,I
in,in,O
the,are,O
of,the,O
APC,APC,B
line,germ,O
familial,familial,B
thought,thought,O
Germ,Line,O
mutations,mutations,O
initiate,initiate,O
and,and,O
gene,of,O
colorectal,sporadic,O
formation,formation,O
somatic,truncating,O
colorectal,colorectal,B
tumor,tumor,I
polyposis,polyposis,I
truncating,somatic,O
,,
I1307K,I1307K,O
lysine,lysine,O
-,-,O
in,6,O
>,>,O
of,of,O
(,(,O
7,7,O
polymorphism,polymorphism,O
Jewish,population,O
the,the,O
identified,identified,O
%,%,O
of,the,O
-,-,O
isoleucine,isoleucine,O
codon,codon,O
population,Jewish,O
has,has,O
gene,gene,O
Ashkenazi,Ashkenazi,O
been,been,O
Recently,Recently,O
.,.,O
%,%,O
an,an,O
-,-,O
1307,1307,O
the,of,O
at,at,O
APC,APC,B
6,in,O
),),O
",",",",O
,,
polymorphism,polymorphism,O
Jewish,subjects,O
the,for,O
analyzed,have,O
APC,APC,B
.,.,O
with,with,O
",",",",I
adenomatous,adenomatous,B
colorectal,colorectal,B
in,in,O
unselected,unselected,O
for,the,O
APC,APC,O
.,.,O
carcinogenesis,carcinogenesis,O
of,this,O
subjects,Jewish,O
allelic,common,O
of,cohort,O
colorectal,colorectal,O
cohort,of,O
and,or,O
the,risk,O
",",",",O
common,variant,O
cancer,cancer,I
To,To,O
I1307K,I1307K,O
assess,assess,O
we,we,O
a,large,O
this,of,O
have,analyzed,O
risk,the,O
large,a,O
or,and,O
variant,allelic,O
polyps,polyps,I
Ashkenazi,Ashkenazi,O
,,
APC,I1307K,O
patients,476,O
(,(,O
was,was,O
I1307K,APC,O
476,patients,O
),),O
.,.,O
identified,identified,O
The,The,O
allele,allele,O
1,1,O
10,10,O
.,.,O
48,48,O
in,in,O
of,of,O
%,%,O
,,
frequency,frequency,O
",",",",O
is,is,O
.,.,O
with,with,O
groups,control,O
estimated,an,O
relative,relative,O
control,groups,O
I1307K,APC,O
1,1,O
in,two,O
separate,separate,O
of,of,O
population,population,O
the,the,O
associated,associated,O
risk,risk,O
an,estimated,O
Compared,Compared,O
allele,I1307K,O
with,with,O
two,in,O
the,the,O
APC,allele,O
,,
1,5,O
5,1,O
-,-,O
.,.,O
,,
=,=,O
both,for,O
7,7,O
.,.,O
01,P,O
),),O
colorectal,colorectal,B
.,.,O
neoplasia,neoplasia,I
(,(,O
P,01,O
for,both,O
,,
carriers,carriers,O
with,noncarriers,O
patient,per,O
numbers,increased,O
(,(,O
diagnosis,at,O
.,.,O
and,and,O
well,well,O
=,=,O
as,as,O
",",",",O
younger,a,O
increased,numbers,O
colorectal,colorectal,B
as,as,O
a,younger,O
of,of,O
adenomas,adenomas,B
APC,APC,O
at,diagnosis,O
03,03,O
P,P,O
had,had,O
noncarriers,with,O
.,.,O
),),O
",",",",O
I1307K,I1307K,O
Furthermore,Compared,O
age,age,O
compared,furthermore,O
",",",",O
per,patient,O
cancers,cancers,I
,,
directly,contributes,O
colorectal,colorectal,B
and,formation,O
of,4,O
I1307K,I1307K,O
leads,variant,O
that,we,O
%,%,O
Jewish,Jewish,O
contributes,directly,O
to,3,O
variant,leads,O
adenoma,adenoma,B
conclude,that,O
formation,and,O
.,.,O
Ashkenazi,Ashkenazi,O
We,Conclude,O
3,to,O
the,the,O
%,%,O
APC,APC,O
-,-,O
increased,increased,O
4,of,O
cancer,cancer,I
all,all,O
to,to,O
,,
-,-,O
prevention,prevention,O
allele,and,O
this,this,O
outcome,term,O
",",",",O
justify,justify,O
The,The,O
of,of,O
term,may,O
clinical,specific,O
studies,outcome,O
risk,risk,O
impact,studies,O
this,this,O
expected,expected,O
360,360,O
harbor,to,O
testing,testing,O
in,in,O
",",",",O
long,long,O
for,for,O
.,.,O
genetic,genetic,O
Americans,Americans,O
cancer,cancer,I
for,for,O
the,the,O
-,-,O
carriers,may,O
setting,setting,O
on,on,O
may,carriers,O
to,harbor,O
estimated,relative,O
colorectal,colorectal,B
population,population,O
specific,clinical,O
significantly,impact,O
and,allele,O
in,in,O
screening,screening,O
the,the,O
000,000,O
may,significantly,O
relative,estimated,O
,,
and,and,O
grade,grade,O
its,loss,O
human,of,O
carcinomas,carcinomas,I
-,-,I
of,human,O
in,its,O
high,high,O
",",",",O
breast,breast,I
-,-,O
Localization,Localization,O
loss,in,O
BRCA1,BRCA1,O
non,non,B
.,.,O
inherited,inherited,I
,,
ovarian,ovarian,I
BRCA1,of,O
the,established,O
suppressor,suppressor,O
and,is,O
",",",",O
in,in,O
non,non,B
hereditary,hereditary,B
gene,gene,O
any,any,O
of,BRCA1,O
established,the,O
and,and,I
is,and,O
cancers,cancers,I
cancer,cancer,I
breast,breast,I
BRCA1,between,O
link,link,O
role,role,O
is,unclear,O
the,the,O
unclear,is,O
",",",",O
tumour,tumour,B
.,.,O
familial,familial,I
-,-,O
",",",",O
if,if,O
Although,Although,O
between,the,O
-,-,I
the,BRCA1,O
,,
of,of,O
reduced,expression,O
-,-,I
BRCA1,BRCA1,O
to,to,O
from,from,O
and,and,I
mutations,are,O
expression,reduced,O
",",",",O
in,rare,O
but,but,O
resulting,BRCA1,O
non,non,B
ovarian,ovarian,I
BRCA1,resulting,O
rare,in,O
in,in,O
is,is,O
important,be,O
loss,loss,O
postulated,postulated,O
cancers,cancers,I
subcellular,localization,O
are,mutations,O
sporadic,sporadic,B
breast,breast,I
familial,familial,I
or,incorrect,O
localization,subcellular,O
be,important,O
incorrect,or,O
.,.,O
cancers,cancers,I
,,
ranged,have,O
from,ranged,O
into,into,O
golgi,golgi,O
of,of,O
to,to,O
nuclear,nuclear,O
due,due,O
",",",",O
not,received,O
",",",",O
.,.,O
general,general,O
proteins,proteins,O
of,of,O
regarding,the,O
BRCA1,BRCA1,O
",",",",O
nuclear,exclusively,O
cytoplasmic,invaginations,O
ER,ER,O
",",",",O
subcellular,localization,O
the,the,O
",",",",O
nucleus,nucleus,O
invaginations,cytoplasmic,O
exclusively,nuclear,O
to,to,O
to,to,O
",",",",O
controversy,controversy,O
/,/,O
Epigenetic,Epigenetic,O
however,loss,O
the,the,O
acceptance,acceptance,O
to,to,O
conditionally,conditionally,O
reports,reports,O
received,not,O
have,from,O
has,has,O
the,regarding,O
localization,subcellular,O
loss,however,O
which,which,O
,,
resolve,this,O
19,comprehensively,O
BRCA1,anti,O
this,resolve,O
attempt,attempt,O
",",",",O
we,we,O
In,An,O
have,have,O
to,to,O
antibodies,antibodies,O
.,.,O
an,in,O
comprehensively,characterized,O
issue,issue,O
characterized,19,O
-,-,O
anti,BRCA1,O
,,
discrete,in,O
those,those,O
from,from,O
.,.,O
protein,protein,O
reagents,these,O
lines,lines,O
These,Reagents,O
detect,detect,O
kD,220,O
in,foci,O
cell,cell,O
derived,derived,O
in,discrete,O
foci,in,O
malignancies,malignancies,I
including,including,O
breast,breast,B
all,epithelial,O
epithelial,all,O
",",",",O
220,kD,O
a,a,O
nuclear,nuclear,O
-,-,O
localized,localized,O
,,
specimens,specimens,O
revealed,also,O
also,revealed,O
human,human,O
.,.,O
BRCA1,BRCA1,O
of,staining,O
and,breast,O
invasive,invasive,B
breast,breast,O
Immunohistochemical,Immunohistochemical,O
staining,of,O
-,-,I
cancers,cancers,I
carcinomas,carcinomas,I
benign,in,O
in,benign,O
foci,nuclear,O
low,low,B
grade,grade,I
nuclear,foci,O
ductal,ductal,I
breast,and,O
",",",",O
lobular,lobular,I
,,
was,was,O
BRCA1,BRCA1,O
sporadic,sporadic,B
undetectable,undetectable,O
the,the,O
ductal,ductal,B
contribute,contribute,O
a,significant,O
expression,reduced,O
to,to,O
pathogenesis,pathogenesis,O
carcinomas,carcinomas,I
.,.,O
.,.,O
grade,grade,O
reduced,BRCA1,O
",",",",O
of,of,O
",",",",O
high,high,O
of,of,O
that,suggesting,O
absence,absence,O
BRCA1,expression,O
cancers,cancers,I
of,percentage,O
",",",",O
in,in,O
percentage,of,O
the,the,O
breast,breast,I
Conversely,Conversely,O
-,-,O
of,of,O
or,or,O
majority,majority,O
significant,a,O
suggesting,that,O
may,may,O
,,
